>0:  2 100.0% 100.0% 1:337
MRAVLLPGSGEQPTAFCYQVNGSCPRTVHPLAIQVVIYLACAVGVLITVLGNLFVVFAVSYFKVLHTPTN
FLLLSLALADMLLGLLVLPLSTVRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPL
LYPSKFTVRTALRYIVAGWGIPAAYTAFFLYTDVVERALSQWLEEMPCVGSCQLLFNKFWGWLNFPAFFV
PCLIMISLYLKIFVVATRQAQQIRTLSQSLAGAVKRERKAAKTLGIAVGIYLVCWLPFTVDTLVDSLLNF
ITPPLVFDIFIWFAYFNSACNPIIYVFSYRWFRKALKLLLSREIFSPRTPTVDLYHD
>1:Q5QD14 Trace amine-associated receptor 5 OS=Mus musculus OX=10090 GN=Taar5 PE=2 SV=1 2 385 4e-133 1 100.0% 100.0% 1:337 1:337
MRAVLLPGSGEQPTAFCYQVNGSCPRTVHPLAIQVVIYLACAVGVLITVLGNLFVVFAVSYFKVLHTPTN
FLLLSLALADMLLGLLVLPLSTVRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPL
LYPSKFTVRTALRYIVAGWGIPAAYTAFFLYTDVVERALSQWLEEMPCVGSCQLLFNKFWGWLNFPAFFV
PCLIMISLYLKIFVVATRQAQQIRTLSQSLAGAVKRERKAAKTLGIAVGIYLVCWLPFTVDTLVDSLLNF
ITPPLVFDIFIWFAYFNSACNPIIYVFSYRWFRKALKLLLSREIFSPRTPTVDLYHD
>2:Q5QD23 Trace amine-associated receptor 5 OS=Rattus norvegicus OX=10116 GN=Taar5 PE=3 SV=1 2 380 3e-131 1 100.0% 96.1% 1:337 1:337
MRAVLLPGSGEQPAAFCYQVNGSCPRTVHPLAIRVLIYLACAVGMLITVLGNLFVVFAVSYFKVLHTPTN
FLLLSLALADMLLGLLVLPLSTVRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPL
LYPSKFTVRIALRYIAAGWGIPAAYTAFFLYTDVVERALSQWLEEMPCVGSCQLLFNKFWGWLNFPAFFI
PCLIMISLYLKIFVVATRQAQQIRTLSQSLSGAVKRERKAAKTLGIAVGIYLVCWLPFTVDTLVDSLLNF
VTPPLVFDIFIWFAYFNSACNPIIYVFSYRWFRKALKLLLSREILSPRTQTADLFHD
>3:O14804 Trace amine-associated receptor 5 OS=Homo sapiens OX=9606 GN=TAAR5 PE=2 SV=2 2 365 2e-125 1 100.0% 86.6% 1:337 1:337
MRAVFIQGAEEHPAAFCYQVNGSCPRTVHTLGIQLVIYLACAAGMLIIVLGNVFVAFAVSYFKALHTPTN
FLLLSLALADMFLGLLVLPLSTIRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPL
LYPSKFTVRVALRYILAGWGVPAAYTSLFLYTDVVETRLSQWLEEMPCVGSCQLLLNKFWGWLNFPLFFV
PCLIMISLYVKIFVVATRQAQQITTLSKSLAGAAKHERKAAKTLGIAVGIYLLCWLPFTIDTMVDSLLHF
ITPPLVFDIFIWFAYFNSACNPIIYVFSYQWFRKALKLTLSQKVFSPQTRTVDLYQE
>4:Q5QD28 Trace amine-associated receptor 5 OS=Pan troglodytes OX=9598 GN=TAAR5 PE=3 SV=1 2 364 1e-124 1 100.0% 86.1% 1:337 1:337
MRAVFIQGAEEHPAAFCYQVNGSCPRTVHTLGIQLVIYLACAAGMLIIVLGNLFVAFAVSYFKALHTPTN
FLLLSLALADMFLGLLVLPLSTIRSVESCWFFGDFLCRLHTYLDPLFCLTSIFHLCFISIDRHCAICDPL
LYPSKFTVRVALRYILAGWGVPAAYTSLFLYTDVVETRLSQWLEEMPCVGSCQLLLNKFWGWLNFPLFFV
PCLIMISLYVKIFVVATRQAQQITTLSKNLAGAAKHDRKAAKTLGIAVGIYLLCWLPFTIDTMVDSLLHF
ITPPLVFDIFIWFAYFNSACNPIIYVFSYQWFRKALKLTLSQKVFSPQTRTVDLYQE
>5:Q923Y2 Trace amine-associated receptor 7a OS=Rattus norvegicus OX=10116 GN=Taar7a PE=3 SV=1 2 311 1e-103 1 99.1% 44.8% 1:337 16:358
MSEDLLSASSPQ---LCynLNGSCIRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGLTVMPFSTVRSVEGCWYFGDTYCKFHSCFEGSFCYSSIFHLCFISVDRYIAVSDPL
IYPTRFTASVSGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSALTCVGGCQIAVNQSWVFINFLLFLV
PTLVMMTVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRQNSSVTNLFPE
>6:Q5QD12 Trace amine-associated receptor 7a OS=Mus musculus OX=10090 GN=Taar7a PE=2 SV=1 2 308 1e-102 1 99.1% 43.6% 1:337 16:358
MNEDLFSATS---TELCynLNRSCVRSPYSPGPRLILYAVFGFGAALAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGLTVMPFSTVRSVEGCWYFGESYCKFHSCFEGSFCYSSIFHLCFISVDRYIAVSDPL
TYPTRFTASVSGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSVLTCVGGCQIAVNQSWVFINFLLFLI
PTLVMMTVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSTTNLFPE
>7:Q5QD11 Trace amine-associated receptor 7b OS=Mus musculus OX=10090 GN=Taar7b PE=2 SV=1 2 307 4e-102 1 97.3% 45.7% 10:337 22:358
---------SATSTELCynLNRSCVRSPYSPGPRLILYAVFGFGAALAVCGNLLVMTSILHFRQLHSPAN
FLVVSLACADFLVGLTVMPFSTVRSVEGCWYFGESYCKLHTCFDVSFCYCSIFHLCFISVDRYIAVSDPL
TYPTRFTAFVSGKCITFSWLLSTIYGFSLLYTGANEAGLEDLVSALTCVGGCQLAVNQSWVFINFLLFLI
PTLVMITVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVLRENSSTTNLFPE
>8:Q923X8 Trace amine-associated receptor 7b OS=Rattus norvegicus OX=10116 GN=Taar7b PE=3 SV=2 2 305 3e-101 1 99.1% 43.3% 1:337 16:358
LSRDLLSASSMQ---LCYelNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGLTVMPFSMVRSVEGCWYFGDIYCKFHSSFDGSFCYSSIFHLCFISADRYIAVSDPL
IYPTRFTASVSGKCITFSWLLSIIYSFSLFYTGVNEAGLEDLVSALTCVGGCQIAVNQSWVFINFLLFLV
PALVMMTVYSKIFLIAKQQAQNIEKMGKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
VTPTYVYEILVWIGYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSATNLFPE
>9:Q5QD09 Trace amine-associated receptor 7e OS=Mus musculus OX=10090 GN=Taar7e PE=2 SV=1 2 304 5e-101 1 97.3% 45.1% 10:337 22:358
---------SATSAELCynLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGLTVMPFSTVRSVEGCWYFGEIYCKLHTCFDVSFCSSSIFHLCFISVDRYIAVSDPL
IYPTRFTASVSNKCITFSWLLSISYGFSLIYTGASEAGLEDLVSALTCVGGCQLAVNQSWVFINFLLFLI
PTLVMITVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSFIDAFLGF
ITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLTVTGKILRENSSTTNLFPE
>10:Q5QD10 Trace amine-associated receptor 7d OS=Mus musculus OX=10090 GN=Taar7d PE=2 SV=1 2 302 2e-100 1 97.3% 43.3% 10:337 22:358
---------SATSTELCynLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGVMVMPFSMVRSVEGCWYFGESYCKFHSCFEGSFCYSSLFHLCFISVDRYIAVSDPL
TYPTRFTASVSGKCITFSWLLSIIYSFSLLYTGANDAGLEDLVSALTCVGGCQIAVNQTWVFINFLLFLI
PTLVMITVYSKIFLIAKQQAQNIEKMSKqkDRVTKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILVWIVYYNSAMNPLIYAFFYSWFRKAIKLIVSGKILRENSSTTNLFPE
>11:Q923Y1 Trace amine-associated receptor 7g OS=Rattus norvegicus OX=10116 GN=Taar7g PE=3 SV=1 2 300 2e-99 1 97.6% 44.4% 9:337 22:358
--------SALSPQLCYENLNRSCVRSPYSPGSRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADLLVGLTVMPFSMVRSVEGCWYFGDSYCKLHSCFDISFCSSSLLHLCFISVDRHIAVSDPL
IYPTRFTASVSGKYITFSWLLSIIYGFSLIYTGASEAGLEDLVSALTCVGGCQVAVNQSWVFINFLLFLV
PALVMMTVYSKIFLIAKQQAQNMEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFVDSIIDAFLGF
ITPTYVYEILAWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILKENSSTINLFPE
>12:Q5QD08 Trace amine-associated receptor 7f OS=Mus musculus OX=10090 GN=Taar7f PE=2 SV=1 2 300 2e-99 1 94.7% 44.5% 19:337 32:358
------------------NLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADFLVGVMVMPFSMVRSVEGCWYFGDSYCKLHTCFDVSFCYCSLFHLCFISVDRYIAVSDPL
AYPTRFTASVSGKCITFSWLLSISYGFSLIYTGASEAGLEDLVSSLTCVGGCQIAVNQTWVFINFSVFLI
PTLVMITVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSFIDAFLGF
ITPTYVYEILVWIVYYNSAMNPLIYAFFYPWFRKAIKLTVTGKILRENSSTTNLFSE
>13:Q5QD04 Trace amine-associated receptor 9 OS=Mus musculus OX=10090 GN=Taar9 PE=2 SV=1 2 299 3e-99 1 97.6% 46.8% 9:337 6:343
--------SPEPPMELCynVNGSCIKSSYAPWPRAILYGVLGLGALLAVFGNLLVIIAILHFKQLHTPTN
FLVASLACADFLVGVTVMPFSTVRSVESCWYFGESYCKFHTCFDTSFCFASLFHLCCISIDRYIAVTDPL
TYPTKFTVSVSGLCIALSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLLFFL
PTVVMVFLYGRIFLVAKYQARKIEGTANqkERVAKRERKAAKTLGIAMAAFLVSWLPYIIDAVIDAYMNF
ITPAYVYEILVWCVYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVFRADSSTTNLFSE
>14:Q5QD21 Trace amine-associated receptor 7c OS=Rattus norvegicus OX=10116 GN=Taar7c PE=3 SV=1 2 299 8e-99 1 99.1% 43.0% 1:337 16:358
LSRDLLSASSLQ---LCynLNRSCVRSPYSPGSRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADLLVGLTVMPFSMVRSVEGCWYFGNTYCKFHSCFEGSFCYSSLFHLCFISLDRYIAVSDPL
IYPTRFTASISGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSALTCVGGCQVAVNQSWVFINFLLFLV
PALVMMTVYSKIFLIAKQQAQNIEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYMYEILVWIVYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSTINLFPE
>15:Q923Y6 Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=3 SV=1 2 297 2e-98 1 94.7% 45.8% 19:337 7:333
------------------NVNGSCIKSSYSPWPRAILYAVLGLGALLAVFGNLLVITAILHFKQLHTPTN
FLVASLACADFLVGVTVMPFSTVRSVEGCWYFGDTYCKFHTCFDTSFCFASLFHLCCISIDRYVAVTDPL
TYPTKFTISVSGVCIALSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLLFFL
PTVVMVFLYGRIFLVAKQQARKIEGSANqkERVARRERKAAKTLGIAMAAFLVSWLPYIIDAVIDAYMNF
ITPAYVYEILVWCVYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVFRADSSRTNLFSE
>16:Q923X6 Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1 2 297 3e-98 1 96.1% 43.2% 14:337 26:358
-------------SQLCynLNRSCIRSPYSPGPRLILHAVFGFSAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADLLVGLTVMPFSMVRSVEGCWYFGDIYCKFHSSFDVSFCYSSIFHLCFISVDRYIAVSDPL
IYLTRFTASVSGKCITFSWFLSIIYSFSLLYTGASEAGLEDLVSALTCVGGCQLAVNQSWVFINFLLFLV
PTLVMMTVYSKVFLIAKQQAQNIEKIGKqkDRVAKRERKAAKTLGITVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSATNLFPE
>17:Q923X5 Trace amine-associated receptor 7d OS=Rattus norvegicus OX=10116 GN=Taar7d PE=3 SV=1 2 297 3e-98 1 99.1% 43.6% 1:337 16:358
LSRDLLSASSLQ---LCynLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLMVMTSILHFRQLHSPAN
FLVASLACADFLVGLTVMPFSMVRSVEGCWYFGDTYCKLHTCFDVSFCYCSLFHLCFISVDRYIAVSDPL
IYPTRFTASVSGKCITFSWLLSIIYGFPLIYTGASEAGLEDLVSALTCVGGCQIPMNQKFVLINFLLFLV
PTLVMMTVYSKIFLIARQQAQNIEKMRKqkDRVCKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDAFLGF
ITPTYVYEILIWIVYYNSSMNPLIYAFFYPWFRKATKLIVTGKILRENSSTINLFPE
>18:Q5QD05 Trace amine-associated receptor 8c OS=Mus musculus OX=10090 GN=Taar8c PE=2 SV=1 2 296 6e-98 1 98.8% 45.6% 5:337 1:344
----MTSNFSQPALQLCynTNGSCIKTPYSPGPRVILYMVYGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQVVVNQDWVLISFLLFFI
PTVVMIILYSKIFLVAKQQAVKIEtsESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDALVDAFMGF
ITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGKILKGHSSTTNLFSE
>19:Q5QD06 Trace amine-associated receptor 8b OS=Mus musculus OX=10090 GN=Taar8b PE=2 SV=1 2 295 1e-97 1 98.8% 46.2% 5:337 1:344
----MTSNFSQPALQLCynTNGSCIKTPYSPGPRVILYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQIVVNQDWVLIDFLLFFI
PTLVMIILYSKIFLVAKQQAVKIEtsESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDSLVDAFVGF
ITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGEILKSHSSTMSLFSE
>20:Q923Y5 Trace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1 2 295 1e-97 1 98.5% 44.3% 6:337 3:343
-----SNSSPPAVLQLCynVNGSCVKTPYSPGPRVLLYAVFGFGAVLAVFGNLLVMISILHFKQLHSPTN
FLIASLACADFWVGVSVMPFSMVRSIESCWYFGRSFCTFHTCCDVAFCYSSLFHLSFISIDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLAYSGAVFYTGVYADGLEEVSDAVNCVGGCQVVVNQNWVLIDFLSFLI
PTLVMIILYGNIFLVARQQAKKIETVGNkkARVARRERKAAKTLGITVVAFMISWLPYSIDSLVDAFMGF
ITPAYIYEICVWCAYYNSAMNPLIYALFYPWFKKAIKVIMSGQVFKNSSATMNLFSE
>21:Q923X9 Trace amine-associated receptor 8a OS=Rattus norvegicus OX=10116 GN=Taar8a PE=3 SV=2 2 294 3e-97 1 98.8% 46.8% 5:337 1:344
----MTSNFSQAPLQLCynVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDAAFCYSSLFHLCFISVDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLVYSSAVFYTGISATGIENLVSALNCVGGCQIVVNQDWVLIDFLLFLI
PTLVMIILYSKIFLVAKQQAVKIEtlESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDTLIDAFMGF
ITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGEILKSHSSTMSLFSE
>22:Q923Y3 Trace amine-associated receptor 8b OS=Rattus norvegicus OX=10116 GN=Taar8b PE=3 SV=1 2 294 5e-97 1 98.8% 45.9% 5:337 1:344
----MTSNFSQATLQLCynVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDAAFCYSSLFHLCFISVDRYIAVTEPL
VYPTKFTMSVSGICISISWILPLVYSSAVFYTGISATGIENLVSALNCVGGCQVAINQDWVLISFLLFFI
PTLVMIILYSKIFLVAKQQAVKIEtlESHKARVAKRERKAAKTLGVTVMAFMVSWLPYTIDTLIDAFMGF
ITPAYVYEICGWIAYYNSAMNPLIYAFFYPWFRKAIKLILSGKILKGHSSTTSLFSE
>23:Q5QD13 Trace amine-associated receptor 6 OS=Mus musculus OX=10090 GN=Taar6 PE=2 SV=1 2 293 8e-97 1 98.5% 43.4% 6:337 3:343
-----SNSSPPTVLQLCynVTGSCVKTPYSPGSRVILYAVFGFGAVLAVFGNLMVMISILHFKQLHSPTN
FLIASLACADFGVGISVMPFSMVRSIESCWYFGRSFCTFHTCCDVAFCYSSLFHLSFISIDRYIAVTDPL
VYPTKFTVSVSGICIGVSWILPLVYSGAVFYTGVYDDGLEELSSALNCVGGCQVVVNQNWVLIDFLSFLI
PTLVMIILYGNIFLVARQQAKKIENieSYKARVARRERKAAKTLGITVVAFMISWLPYSIDSLVDAFMGF
ITPAYIYEICVWCAYYNSAMNPLIYALFYPWFKKAIKVIMSGQVFKNSSATMNLFSE
>24:Q923Y4 Trace amine-associated receptor 7h OS=Rattus norvegicus OX=10116 GN=Taar7h PE=3 SV=1 2 292 3e-96 1 97.6% 42.9% 9:337 22:358
--------SALSPQLCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPAN
FLVASLACADLLVGLTVMPFSMVRSVEGCWYFGDSYCKLHTSFDMSFCCSSLLHLCFISVDRYIAVSDPL
IYPIRFTASVSGKCITFSWFLSIIYGFSLIYTGASEAGLKDLVSALSCVGGCQIPMNQSCVLINFLLFLV
PTLVMMTVYSKIFLIAKQQAQNMEKMSKqkDRVAKRERKAAKTLGIAVAAFLLSWLPYLIDSIIDAFLGF
ITPSYVYEILVWIVYYNSAMNPLIYAFFYPWFRNAIKLIVTGKILKQNSSTTNLFSE
>25:Q923Y0 Trace amine-associated receptor 8c OS=Rattus norvegicus OX=10116 GN=Taar8c PE=3 SV=1 2 291 3e-96 1 98.8% 45.9% 5:337 1:344
----MTSNFSQATLQLCynVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLVYSSAVFYTGISAMGIENLVSALNCVGGCQVVVNQDWVLISFLLFFI
PTLVMIILYSKIFLVAKQQAVKIEtlESHKARVAKRERKAAKTLGVTVLAFIVSWLPYTIDTLIDAFMGF
ITPAYVYEFCCWSAYYNSAMNPLIYAFFYPWFRKAMKLILSGKILKGHSSTTSLFSE
>26:Q5W8W0 Trace amine-associated receptor 6 OS=Pan troglodytes OX=9598 GN=TAAR6 PE=3 SV=1 2 290 2e-95 1 95.0% 44.1% 18:337 16:343
-----------------PNVNGSCVETLYSPGSRVILYIVFGFGAVLAVFGNLLVMISILHFKQLHSPTN
FLVASLACADFLVGVTVMPFSMVRTVESCWYFGRSFCTFHTCCDVAFCYSSLFHLCFISIDRYIAVTDPL
VYPTKFTVSVSGICISVSWILPLMYSGAVFYTGVYDDGLEELSDALNCIGGCQTVVNQNWVLIDCLSFFI
PTFIMIILYGNIFLVARRQAKKIEnsESYKARVARRERKAAKTLGVTVVAFMISWLPYSIDSLIDAFMGF
ITPAYIYEICCWCAYYNSAMNPLIYALFYPWFRKAIKVIVTGQVLKNSSATMNLFSE
>27:Q5QD07 Trace amine-associated receptor 8a OS=Mus musculus OX=10090 GN=Taar8a PE=2 SV=1 2 289 2e-95 1 98.8% 45.0% 5:337 1:344
----MTSNFSQPALQLCynTNGSCIKTPYSPGPRVILYMVYGFGAVLAVCGNLLVVISVLHFKQLHSPAN
FLIASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSVLHLCFISVDRYIAVTDPL
VYPTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQIVINQDFVLISFLLFFI
PTLVMIILYSKIFLVAKQQAVKIEtsESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDALVDAFMGF
ITPAYVYEICCWGTYYNSAMNPLIYAFFFPWFKKAIKLILSGEILKGHSSTANLFSE
>28:Q96RI9 Trace amine-associated receptor 9 OS=Homo sapiens OX=9606 GN=TAAR9 PE=2 SV=1 2 289 5e-95 1 94.7% 46.4% 19:337 17:343
------------------NVNESCIKTPYSPGPRSILYAVLGFGAVLAAFGNLLVMIAILHFKQLHTPTN
FLIASLACADFLVGVTVMPFSTVRSVESCWYFGDSYCKFHTCFDTSFCFASLFHLCCISVDRYIAVTDPL
TYPTKFTVSVSGICIVLSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLLFFI
PNVAMVFIYSKIFLVAKHQARKIESTASQAQSSskRERKAAKTLGIAMAAFLVSWLPYLVDAVIDAYMNF
ITPPYVYEILVWCVYYNSAMNPLIYAFFYQWFGKAIKLIVSGKVLRTDSSTTNLFSE
>29:Q96RI8 Trace amine-associated receptor 6 OS=Homo sapiens OX=9606 GN=TAAR6 PE=2 SV=1 2 288 6e-95 1 94.7% 44.2% 19:337 17:343
------------------NVNGSCVKIPFSPGSRVILYIVFGFGAVLAVFGNLLVMISILHFKQLHSPTN
FLVASLACADFLVGVTVMPFSMVRTVESCWYFGRSFCTFHTCCDVAFCYSSLFHLCFISIDRYIAVTDPL
VYPTKFTVSVSGICISVSWILPLMYSGAVFYTGVYDDGLEELSDALNCIGGCQTVVNQNWVLTDFLSFFI
PTFIMIILYGNIFLVARRQAKKIEnsESYKARVARRERKAAKTLGVTVVAFMISWLPYSIDSLIDAFMGF
ITPACIYEICCWCAYYNSAMNPLIYALFYPWFRKAIKVIVTGQVLKNSSATMNLFSE
>30:Q5QD25 Trace amine-associated receptor 2 OS=Rattus norvegicus OX=10116 GN=Taar2 PE=2 SV=1 2 277 2e-90 1 97.0% 41.9% 9:335 5:333
--------EAQQETFDCSEynGSCPENERSLGVRAAMYSLMAGAIFITIFGNLVMIISISYFKQLHTPTN
LLILSMAVTDFLLGFTIMPYSMVRSVENCWYFGLTFCKIHYSFDLMLSITSIFHLCSVAIDRFYAICHPL
HYCTKMTIPVVKRLLLVCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFVafFT
PSSMMVGIYGKIFAVSKKHARVIDNLPENQNNQMRKDKKAAKTLGIVMGVFLLCWFPCFFTILLDPFLNF
STPAILFDALTWFGYFNSTCNPLIYGFFYPWFRRALRYILLGKIFSSHFHNTNLF--
>31:P07700 Beta-1 adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB1 PE=1 SV=1 2 281 2e-90 1 84.3% 36.5% 37:321 44:358
------------------------------------MSLLMALVVLLIVAGNVLVIAAIGRTQRLQTLTN
LFITSLACADLVMGLLVVPFGATLVVRGTWLWGSFLCECWTSLDVLCVTASIETLCVIAIDRYLAITSPF
RYQSLMTRARAKVIICTVWAISALVSFLPIMMHWWRDEDPQALKCYQDPGCCDFVTNRAYAisSIISFYI
PLLIMIFVYLRVYREAKEQIRKIDRcrKTSRVMAMREHKALKTLGIIMGVFTLCWLPFFLVNIVNVFNRD
LVPDWLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFKRLLC----------------
>32:Q969N4 Trace amine-associated receptor 8 OS=Homo sapiens OX=9606 GN=TAAR8 PE=2 SV=1 2 277 2e-90 1 98.8% 43.5% 5:337 1:342
----MTSNFSQPVVQLCYevNGSCIETPYSPGSRVILYTAFSFGSLLAVFGNLLVMTSVLHFKQLHSPTN
FLIASLACADFLVGVTVMLFSMVRTVESCWYFGAKFCTLHSCCDVAFCYSSVLHLCFICIDRYIVVTDPL
VYATKFTVSVSGICISVSWILPLTYSGAVFYTGVNDDGLEELVSALNCVGGCQIIVSQGWVLIDFLLFFI
PTLVMIILYSKIFLIAKQQAIKisSSESYKIRVAKRERKAAKTLGVTVLAFVISWLPYTVDILIDAFMGF
LTPAYIYEICCWSAYYNSAMNPLIYALFYPWFRKAIKLILSGDVLKASSSTISLFLE
>33:P18841 Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 2 282 2e-90 1 89.9% 30.8% 15:326 26:369
--------------TGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTN
YFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSL
QYPTLVTRRKAILALLSVWVLSTVISIGPLL---------GWKEPAPNDDkcGVTEEPFYafSSLGSFYI
PLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSkrEKKAAKTLGIVVGMFILCWLPFFIALPLGSLFST
LKPpaVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRS-----------
>34:P15823 Alpha-1B adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1b PE=1 SV=2 2 281 5e-90 1 89.3% 30.6% 15:324 26:367
--------------TGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTN
YFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSL
QYPTLVTRRKAILALLSVWVLSTVISIGPLL---------GWKEPAPNDDkcGVTEEPFYafSSLGSFYI
PLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSkrEKKAAKTLGIVVGMFILCWLPFFIALPLGSLFST
LKPpaVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQC-------------
>35:Q5QD17 Trace amine-associated receptor 2 OS=Mus musculus OX=10090 GN=Taar2 PE=2 SV=1 2 275 8e-90 1 97.0% 41.9% 9:335 5:333
--------EAQQETFDCSEynGSCPENERSLGVRAAMYSLMACAIFITIFGNLAMIISISYFKQLHTPTN
LLILSMAVTDFLLGFTIMPYSMVRSVENCWYFGLTFCKIHYSFDLMLSITSIFHLCSVAVDRFYAICHPL
HYCTKMTIPVVRRLLLVCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFVafFT
PSSMMVGIYGKIFAVSKKHARVIDNLPENQNNQMRKDKKAAKTLGIVMGVFLLCWFPCFFTILLDPFLNF
STPAVLFDALTWFGYFNSTCNPLIYGFFYPWFRRALKYILLGKIFSSHFHNTNLF--
>36:Q5QD15 Trace amine-associated receptor 4 OS=Mus musculus OX=10090 GN=Taar4 PE=2 SV=1 2 273 4e-89 1 97.9% 41.2% 7:336 6:344
------PWSSPEVQFCFAAANSSCPRKARPALVVCAMYLIMIGAIVMTMLGNMAVIISIAHFKQLHSPTN
FLILSMATTDFLLSCVVMPFSMIRSIESCWYFGDLFCKVHSCCDIMLCTTSIFHLCFISVDRHYAVCDPL
HYVTQITTRVVGVFLLISWSVPIFFAFGLVFSELNLIGAEDFVAAIDCTGLCVLIFNKLWGVlsFIAFFL
PGTVMVGIYIHIFTVAQKHARQIGtsESKMKATSKKESKATKTLSIVMGVFVLCWLPFFVLTITDPFIDF
TTPEDLYNVFLWLGYFNSTFNPIIYGMFYPWFRKALRMIVTGTIFRSDSSTSSLHP-
>37:P04274 Beta-2 adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRB2 PE=1 SV=1 2 276 5e-89 1 95.5% 30.7% 8:330 2:350
-------GPPGNDSDFLLTTNGsdVTEERDEAWVVGMAILMSVIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYIAITSPF
KYQSLLTKNKARMVILMVWIVSGLTSFLPIQMHWYRATHQKAIDCYHKETCCDFFTNQAYAisSIVSFYV
PLVVMVFVYSRVFQVAKRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIPKEVYILLNWLGYVNSAFNPLIYC-RSPDFRIAFQELLCLRRSSSKAY-------
>38:P43141 Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 2 275 1e-88 1 91.1% 33.4% 21:328 8:336
--------------------NGSVPNCSWalSRQWAVGAALSITILVIVAGNLLVIVAIAKTPRLQTMTN
VFVTSLACADLVMGLLVVPPGATILLSGHWPYGTVVCELWTSLDVLCVTASIETLCAIAVDRYLAITAPL
QYEALVTKGRAWAVVCMVWAISAFISFLPIMNHWWRDGaeQAVRCYDDPRCCDFVTNMTYAIVSsvSFYV
PLLVMIFVYVRVFAVATRHVQLigRWRRPSRLLAIKEHKALKTLGIIMGTFTLCWLPFFVANIIKVFCRP
LVPDQLFLFLNWLGYVNSAFNPIIYC-RSPDFRSAFRKLLCCPRRADR---------
>39:P18762 Beta-2 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb2 PE=1 SV=2 2 274 2e-88 1 95.5% 31.0% 8:330 2:350
-------GPHGNDSDFLLAPNGsdVTQERDEAWVVGMAILMSVIVLAIVFGNVLVITAIAKFERLQTVTN
YFIISLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYVAITSPF
KYQSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKKAIDCYTEETCCDFFTNQAYAisSIVSFYV
PLVVMVFVYSRVFQVAKRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIRDN
LIPKEVYILLNWLGYVNSAFNPLIYC-RSPDFRIAFQELLCLRRSSSKTY-------
>40:P35368 Alpha-1B adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1B PE=1 SV=3 2 277 2e-88 1 89.6% 29.7% 15:324 26:367
--------------TGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTN
YFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSL
QYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYafSSLGSFYI
PLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSkrEKKAAKTLGIVVGMFILCWLPFFIALPLGSLFST
LKPpaVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQC-------------
>41:Q923Y7 Trace amine-associated receptor 4 OS=Rattus norvegicus OX=10116 GN=Taar4 PE=3 SV=1 2 271 3e-88 1 96.7% 41.7% 11:336 9:344
----------SPETQFCFAanNSCPRKARPALVVCAMYLVMIGAIVMTMLGNMVVIISIAHFKQLHSPTN
FLILSMATTDFLLSCVVMPFSMVRSIESCWYFGDLFCKVHSCCDIMLCTTSIFHLCFISVDRHYAVCDPL
HYVTQITVGVVGVFLLISWSVPILFAFGLVFSELNLIGAEDFVAAIDCTGLCVLIFNKLWGVlsFIAFFL
PGAIMVGIYIHIFTVARKHARKIGpsESKMKATSGKESKATKTLSIVMGVFVLCWLPFFVLTITDPFIGF
TTPEDLYNVFLWLGYFNSTFNPIIYGMFYPWFRKALRMIVTGTIFRSDSSTSSLHP-
>42:Q9TST5 Beta-2 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB2 PE=3 SV=1 2 274 3e-88 1 87.2% 30.8% 27:321 26:341
--------------------------QERNDAWVVGMGIVMSLIVLAIVFGNVLVITAIARFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPF
KYQSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAisSIVSFYL
PLVVMVFVYSRVFQVAQRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIPKEVYILLNWVGYVNSAFNPLIYC-RSPDFRIAFQELLC----------------
>43:P10608 Beta-2 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb2 PE=1 SV=1 2 273 5e-88 1 93.8% 30.9% 14:330 13:350
-------------APNGSRAPGHDITQERDEAWVVGMAILMSVIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYVAITSPF
KYQSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKQAIDCYAKETCCDFFTNQAYAisSIVSFYV
PLVVMVFVYSRVFQVAKRQLQKIDKSerSSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIRAN
LIPKEVYILLNWLGYVNSAFNPLIYC-RSPDFRIAFQELLCLRRSSSKTY-------
>44:Q28997 Beta-2 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB2 PE=2 SV=2 2 272 7e-88 1 93.5% 30.7% 8:323 2:343
-------GQPGNRSVFLLAPNGsaPDQDVpeAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWTFGSFWCEFWISIDVLCVTASIETLCVIAVDRYLAITSPF
KYQCLLTKNKARVVILMVWVVSGLISFLPIKMHWYQATHREALNCYAEEACCDFFTNQPYAisSIVSFYL
PLVVMVFVYSRVFQVARRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHGIHDN
LIPKEVYILLNWVGYVNSAFNPLIYC-RSPDFRMAFQELLCLH--------------
>45:Q4KWL2 Beta-2 adrenergic receptor OS=Tscherskia triton OX=329627 GN=ADRB2 PE=2 SV=1 2 272 7e-88 1 92.9% 31.2% 8:321 2:341
-------GPPGNDSDFLLTPNGsdITQERDEAWVVGMAILMSVIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYIAITSPF
KYQSLLTKNKARMVILMVWIVSGLTSFLPIQMHWYRATHEKAITCYRNETCCDFFTNQAYAisSIVSFYV
PLVVMVFVYSRVFQVAKRQLQKIDKSEGRFHSQnlKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQEN
LIPKEVYILLNWLGYVNSAFNPLIYC-RSPDFRIAFQELLC----------------
>46:Q28509 Beta-2 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB2 PE=2 SV=1 2 272 1e-87 1 92.9% 30.9% 8:321 2:341
-------GQPGNGSAFLLAPNGsdVTQERDEAWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPF
KYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAisSIVSFYV
PLVIMVFVYSRVFQEAKRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIPKEVYILLNWVGYVNSGFNPLIYC-RSPDFRIAFQELLC----------------
>47:P54833 Beta-2 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB2 PE=2 SV=1 2 272 1e-87 1 92.9% 30.6% 8:321 2:341
-------GQPANRSVFLLAPNGsgDSQERSEAWVVGMGIVMSLIVLAIVFGNVLVITAIARFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPF
KYQSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAisSIVSFYL
PLVVMVFVYSRVFQVAQRQLQKIDRSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIPKEVYILLNWVGYVNSAFNPLIYC-RSPDFRIAFQELLC----------------
>48:P97717 Alpha-1B adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1b PE=1 SV=2 2 275 1e-87 1 90.2% 31.3% 12:324 21:366
-----------KDANFTGPNQTSSNSTLPQLDVTRAISVGcgAFILFAIVGNILVILSVACNRHLRTPTN
YFIVNLAIADLLLSFTDLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSL
QYPTLVTRRKAILALLSVWVLSTVISIGPLL---------GWKEPAPNDDkcGVTEEPFYafSSLGSFYI
PLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSkrEKKAAKTLGIVVGMFILCWLPFFIALPLGSLFST
LKPpaVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQC-------------
>49:P07550 Beta-2 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB2 PE=1 SV=3 2 270 8e-87 1 92.9% 30.3% 8:321 2:341
-------GQPGNGSAFLLAPNGsdVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPF
KYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAisSIVSFYV
PLVIMVFVYSRVFQEAKRQLQKIDKSEGRFhkFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELLC----------------
>50:P97718 Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3 2 271 8e-87 1 92.6% 29.8% 15:333 7:354
--------------NASEGSNCTHPPAQVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPL
RYPTIVTQRRGVRALLCVWALSLVISIGPLFGWRQQAPEDETICQINEEPG-------YVLFSALGSFYV
PLTIILVMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfnF
KPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKH----
>51:Q9P1P5 Trace amine-associated receptor 2 OS=Homo sapiens OX=9606 GN=TAAR2 PE=2 SV=2 2 267 8e-87 1 91.1% 44.3% 21:327 30:337
--------------------NRSCPENERSLGVRVAMYSFMAGSIFITIFGNLAMIISISYFKQLHTPTN
FLILSMAITDFLLGFTIMPYSMIRSVENCWYFGLTFCKIYYSFDLMLSITSIFHLCSVAIDRFYAICYPL
LYSTKITIPVIKRLLLLCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFMafFT
PGSMMVGIYGKIFAVSRKHAHAINNLRENQNNQVKKDKKAAKTLGIVIGVFLLCWFPCFFTILLDPFLNF
STPVVLFDALTWFGYFNSTCNPLIYGFFYPWFRRALKYILLGKIFSS----------
>52:Q8K4Z4 Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1 2 270 9e-87 1 85.8% 31.0% 32:321 31:341
-------------------------------AWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPF
KYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAisSIVSFYL
PLVVMVFVYSRVFQVAKKQLQKIDRSEGRFhkFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDN
LIPKEVYILLNWVGYVNSAFNPLIYC-RSPDFRIAFQELLC----------------
>53:O02824 Alpha-1A adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1A PE=2 SV=1 2 271 1e-86 1 92.9% 29.7% 14:333 6:354
-------------GNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPL
RYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPG-------YVLFSALGSFYV
PLTIILAMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfdF
KPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKH----
>54:Q9WU25 Alpha-1A adrenergic receptor OS=Cavia porcellus OX=10141 GN=ADRA1A PE=2 SV=2 2 271 1e-86 1 90.8% 30.7% 21:333 11:354
--------------------SSNCTQPPAPVNIpiLLGVILGVLILFGVPGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMSLCIISIDRYIGVSYPL
RYPTIVTQRRGLRALLCLWALSLVISIGPLFGWRQPAPQDETICQINEDPS-------YVLFSALGSFYV
PLAIILVMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfdF
KPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKH----
>55:P43140 Alpha-1A adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1a PE=2 SV=1 2 270 3e-86 1 92.6% 29.2% 15:333 7:354
--------------NASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPL
RYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPG-------YVLFSALGSFYV
PLAIILVMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfdF
KPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKH----
>56:Q91175 Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 2 270 4e-86 1 87.2% 31.8% 35:336 27:354
----------------------------------VVLGMVLGIFILFGVIGNILVILSVVCHRHLQTVTY
YFIVNLAVADLLLSSTVLPFSAIFEILDRWVFGRVFCNIWAAVDVLCCTASIMSLCVISVDRYIGVSYPL
RYPAIMTKRRALLAVMLLWVLSVIISIGPLFGWKEPAPE----DETVCKITEEPGYAIF---SAVGSFYL
PLAIILAMYCRVYVVAQKESRGLKEGQKIEKSDSEqeKKAAKTLGIVVGCFVLCWLPFFLVLPIGSIFPA
YRpdTVFKITFWLGYFNSCINPIIYLCSNQEFKKAFQSLLGVHCLR-MTPRAHHHH-
>57:P35348 Alpha-1A adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1A PE=1 SV=2 2 267 3e-85 1 92.9% 29.1% 14:333 6:354
-------------GNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPL
RYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPG-------YVLFSALGSFYL
PLAIILVMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfdF
KPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKH----
>58:Q9TT96 Beta-1 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB1 PE=3 SV=2 2 267 7e-85 1 93.2% 31.7% 4:322 32:380
---LLVPASPPASLLTSASEGPPLPSQQWTAG----MGLLMAFIVLLIVVGNVLVLVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARALVCTVWAISALVSFLPIFMQWWGDKDAKASRCYNDPECCDFIINeyAITSSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLSGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLLCC---------------
>59:Q28044 Beta-2 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB2 PE=2 SV=2 2 265 8e-85 1 85.8% 30.3% 32:321 31:341
-------------------------------AWVVGMGILMSLIVLAIVFGNVLVITAIAKFERLQTVTN
YFITSLACADLVMGLAVVPFGACHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYLAITSPF
KYQCLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRASHKEAINCYAKETCCDFFTNQPYAisSIVSFYL
PLVVMVFVYSRVFQVAKRQLQKIDKSEGRFhkFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIKDN
LIRKEIYILLNWLGYINSAFNPLIYC-RSPDFRIAFQELLC----------------
>60:Q5QD16 Trace amine-associated receptor 3 OS=Mus musculus OX=10090 GN=Taar3 PE=2 SV=1 2 262 1e-84 1 94.1% 42.9% 21:337 18:341
--------------------NKSCPPTNRSFRVRMIMYLFMTGAMVITIFGNLVIIISISHFKQLHSPTN
FLILSMATTDFLLGFVIMPYSMVRSVESCWYFGDSFCKFHASFDMMLSLTSIFHLCSIAIDRFYAVCDPL
HYTTTMTVSMIKRLLAFCWAAPALFSFGLVLSEANVSGMQSYEILVACFNFCALTFNKFWGTILftCFFT
PGSIMVGIYGKIFIVSRRHARALSDMPAnkNLSKKKDRKAAKTLGIVMGVFLACWLPCFLAVLIDPYLDY
STPIIVLDLLVWLGYFNSTCNPLIHGFFYPWFRKALQFIVSGKIFRSNSDTANLFPE
>61:P18130 Alpha-1A adrenergic receptor OS=Bos taurus OX=9913 GN=ADRA1A PE=2 SV=1 2 266 1e-84 1 92.9% 28.8% 14:333 6:354
-------------GNASDSSNCTHPPPPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTH
YYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNVWAAVDVLCCTASIMGLCIISIDRYIGVSYPL
RYPTIVTQKRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPG-------YVLFSALGSFYV
PLTIILVMYCRVYVVAKRESRGlkTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFfdF
RPSETVFKIAFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRKQSSKH----
>62:P53454 D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1 2 266 1e-84 1 92.0% 30.8% 23:337 28:367
----------------------DVPAPVGGVSVRALTGCVLCALIVSTLLGNTLVCAAVIKFRHLRsvTN
AFVVSLAVSDLFVAVLVMPWRAVSEVAGVWLFGRF-CDTWVAFDIMCSTASILNLCVISMDRYWAISNPF
RYERRMTRRFAFLMIAVAWTLSVLISFIPVQLNWHRADNNSSAHEQ---GDCNASLNRTYAisSLISFYI
PVLIMVGTYTRIFRIAQTQIRRISSLEraLKTSFKRETKVLKTLSVIMGVFVFCWLPFFVLNCVVPFCDv
cVSDTTFNIFVWFGWANSSLNPVIYAF-NADFRKAFTTILGCSKFCSSsqAVDFSNE
>63:P42290 D(1B) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd5 PE=2 SV=1 2 265 2e-84 1 94.1% 32.9% 19:337 26:378
------------------SVSRESQRRKELVAGQIVTGSLLLLLIFWTLFGNILVCTAVMRFRHLRsvTN
IFIVSLAVSDLLVALLVMPWKAVAEVAGHWPFGAF-CDIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTQRVALLMISTAWALSVLISFIPVQLSWHKSETEDHLLSNHSTGNCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAQIQIKRISTLErsLRTSIKKETKVLKTLSIIMGVFVCCWLPFFILNCMVPFCDr
cVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFSSLLGCGHWCSTTptVNISNE
>64:Q28927 Beta-1 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB1 PE=2 SV=2 2 266 2e-84 1 85.2% 34.0% 35:322 59:380
----------------------------------VGMGLLMAFIVLLIVAGNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARALVCTVWAISALVSFLPIFMQWWGDKDAKASRCYNDPECCDFIINeyAITSSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLSGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLLCC---------------
>65:Q5QD24 Trace amine-associated receptor 3 OS=Rattus norvegicus OX=10116 GN=Taar3 PE=3 SV=1 2 261 2e-84 1 94.1% 42.3% 21:337 18:340
--------------------NKSCPPTNRSFRVRLIMYLLMTGAMVITIFGNLVIIISISHFKQLHSPTN
FLILSMATTDFLLGFVIMPYSMVRSVESCWYFGDSFCKFHASFDMMLSLTSIFHLCSIAIDRFYAVCAPL
HYTTTMTASMIKRLLFFCWAAPALFSFGLVLSEANVSGMQSYEILIACFNFCALTFNKFWGTILftCFFT
PGSIMVGIYGKIFIVSRRHARALGNMPEnrNLSKKKDRKAAKTLGIVMGVFLACWLPCFLAVLIDPYLDY
STPIIVLDLLVWLGYFNSTCNPLIHGFFYPWFRKALEHIVSGKIFRSNSDTANLFPE
>66:Q5QNP2 Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1 2 261 3e-84 1 97.9% 43.6% 6:335 3:339
-----LSSQEYDPSQFCFpvNNSCLKGTHHVSTQTVVYLILASAMTVTVLGNSVVIISIAHFKQLQTPTN
ILVMSLALADLLLGLVVMPFSMIRSVDGCWYYGETFCLLHTGFDLFLTSVSIFHLIFIAVDRHQAVCFPL
QYPTRITIPVAWVMVMISWSMAAFYSYGVVYSKANLEGLEEYIASVYCMGGCTLYFNALWSVltLLTFFL
PCSVMVGLYARIFVVAKKHIKSITEANQnfKNPRRSERKAAKTLGIVVGAFILCWLPFFINSLVDPYINF
STPYALFDAFGWLGYTNSTLNPIIYGLFYPWFRKTLSLIVTLRIFEPNSSDINLF--
>67:P79148 Beta-1 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB1 PE=3 SV=1 2 264 1e-83 1 94.1% 32.1% 2:322 29:390
-AARLLVPASPSASPLAPTSEGPAPLSQQ---WTAGIGLLMALIVLLIVAGNVLVIAAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVMRGRWEYGSFLCELWTSVDVLCVTASIETLCVIALDRYLAITAPF
RYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAGGDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRRAFQRLLCC---------------
>68:P25115 D(1B) dopamine receptor OS=Rattus norvegicus OX=10116 GN=Drd5 PE=2 SV=1 2 263 2e-83 1 90.2% 32.4% 32:337 36:387
-------------------------------PAQVVTAGLLTLLIVWTLLGNVLVCAAIVRSRHLrkMTN
IFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGTF-CDIWVAFDIMCSTASILNLCIISVDRYWAISRPF
RYERKMTQRVALVMVGLAWTLSILISFIPVQLNWHrtPWEEGWELEGRTENCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAQVQIRRISSLErsLRASIKKETKVFKTLSMIMGVFVCCWLPFFILNCMVPFCSs
cVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFAQLLGCSHFCFRTptVNISNE
>69:O70528 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1 2 260 2e-83 1 88.7% 33.8% 34:332 19:339
---------------------------------KVVLLTFLSAVILMAILGNLLVMVAVCRDRQLRKitN
YFIVSLAFADLLVSVLVMPFGAIELVQDIWVYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAicQPL
VYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDLIeqNSNSTYCVFMVNKPYAItsVVAFYI
PFLLMVLAYYRIYVTAKEHARQIQVLqqHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDY
TVPGQLWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSI-----
>70:Q8BLD9 D(1B) dopamine receptor OS=Mus musculus OX=10090 GN=Drd5 PE=2 SV=1 2 263 2e-83 1 90.2% 32.4% 32:337 36:387
-------------------------------PAQVVTAGLLTLLIVWTLLGNVLVCAAIVRSRHLrkMTN
IFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAF-CDIWVAFDIMCSTASILNLCIISVDRYWAISRPF
RYERKMTQRVALVMVALAWTLSILISFIPVQLNWheTPWEEGWELDGRTENCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAQVQIRRISSLErsLRASIKKETKVFKTLSVIMGVFVCCWLPFFILNCMVPFCSs
cVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFAQLLGCSHLCFRTptVNISNE
>71:Q9TST6 Beta-1 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB1 PE=3 SV=1 2 262 4e-83 1 93.8% 31.9% 2:321 29:388
-AARLLVPASPSASPLTPTSEGPAPLSQQ---WTAGIGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVMRGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAEGDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLSGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLLC----------------
>72:O42574 Beta-1 adrenergic receptor OS=Xenopus laevis OX=8355 GN=adrb1 PE=2 SV=1 2 259 5e-83 1 87.8% 33.7% 23:322 19:341
----------------------TVPSPMHPLpwTMGMTMFMAAIILLIVMGNIMVIVAIGRNQRLQTLTN
VFITSLACADLIMGLFVVPLGATLVVSGRWLYGSIFCEFWTSVDVLCVTASIETLCVISIDRYIAITSPF
RYQSLLTKGRAKGIVCSVWGISALVSFLPiwRDTGDPLAMKCYEDPGC---CDFVTNRAYAisSIISFYF
PLIIMIFVYIRVFKEAQKQMKKIDKCEGRFSHShaKEQKALKTLGIIMGTFTLCWLPFFLANVVNVFYRN
LIPDKLFLFLNWLGYANSAFNPIIYC-RSPDFRKAFKRLLCC---------------
>73:Q8HZ64 Trace amine-associated receptor 1 OS=Macaca mulatta OX=9544 GN=TAAR1 PE=3 SV=1 2 257 7e-83 1 95.8% 40.6% 15:337 2:335
--------------PFCHNinISCVKNNWSNDVRASLYSLMALIILTTLVGNLIVIVSISHFKQLHTPTN
WLIHSMATVDFLLGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPL
RYKAKINILVVCVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLAftSFYI
PGSIMLCIYYRIYLIAKEQARSINDANQKLQIGLEmeRKAVKTLGIVMGVFLICWCPFFVCTVIDPFLHY
TIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMILFGKIFQKDSSRCKLFLE
>74:Q96RJ0 Trace amine-associated receptor 1 OS=Homo sapiens OX=9606 GN=TAAR1 PE=2 SV=1 2 256 2e-82 1 95.8% 40.2% 15:337 3:336
--------------PFCHNinISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISHFKQLHTPTN
WLIHSMATVDFLLGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPL
RYKAKMNILVICVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLTftSFYI
PGSIMLCVYYRIYLIAKEQARLISDANQKLQIGLEmeRKAVKTLGIVMGVFLICWCPFFICTVMDPFLHY
IIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMMLFGKIFQKDSSRCKLFLE
>75:P97288 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 2 258 2e-82 1 88.7% 34.1% 34:332 19:339
---------------------------------KVVLLTFLAVVILMAILGNLLVMVAVCRDRQLRKitN
YFIVSLAFADLLVSVLVMPFGAIELVQDIWAYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAicQPL
VYRNKMTPLRIALMLGGCWVLPMFISFLPIMQGWNNIGIVDVIehNSNSTWCVFMVNKPYAItsVVAFYI
PFLLMVLAYYRIYVTAKEHAQQIQMLqqHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDPFIDY
TVPEQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYKRPPI-----
>76:Q13639 5-hydroxytryptamine receptor 4 OS=Homo sapiens OX=9606 GN=HTR4 PE=1 SV=2 2 258 2e-82 1 88.7% 34.1% 34:332 19:339
---------------------------------KVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKitN
YFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAicQPL
VYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIeqNSNSTYCVFMVNKPYAItsVVAFYI
PFLLMVLAYYRIYVTAKEHAHQIQMLqqHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDY
TVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSI-----
>77:Q28998 Beta-1 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB1 PE=2 SV=2 2 260 2e-82 1 86.6% 34.0% 37:330 61:391
------------------------------------MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLT-RAARALVCTVWAISALVSFLPILMHWWRDKGAEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLGSParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLLCCARRVARGS-------
>78:Q9VCZ3 Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 2 261 3e-82 1 92.9% 31.6% 9:321 82:420
--------AGQAQDIQASEGSTDDADGSSHLALVFVKCFIIGFIILAAILGNMLVIVSVMRHRKLRIITN
YFVVSLAVADMLVALCAMTFNASVMISGKWMFGSVMCDMWNSFDVYFSTASIMHLCCISVDRYYAIVQPL
DYPLIMTQRRVFIMLLMVWLSPALLSFLPICSGWYTTTENYKYLKSNPHICEFKVNKAYAIVSSSMSFWI
PGIVMLSMYYRIYQEADRQERLVyqVEQSTISTMRRERKAARTLGIIMSAFLICWLPFFLWYIVSSLCdc
ITPRLLVGILFWIGYFNSALNPIIYAYFNRDFRAAFKKTLK----------------
>79:Q923Y8 Trace amine-associated receptor 1 OS=Mus musculus OX=10090 GN=Taar1 PE=2 SV=1 2 255 5e-82 1 93.8% 41.1% 20:335 8:331
-------------------TNISHRNSDWSREVQASLYSLMSLIILATLVGNLIVIISISHFKQLHTPTN
WLLHSMAIVDFLLGCLIMPCSMVRTVERCWYFGEILCKVHTSTDIMLSSASIFHLAFISIDRYCAVCDPL
RYKAKINISTILVMILVSWSLPAVYAFGMIFLELNLKGVEeyRSQVSDLGGCSPFFSKVSGVLAftSFYI
PGSVMLFVYYRIYFIAKGQARSINrlEGKSQAPQSKETKAAKTLGIMVGVFLVCWCPFFLCTVLDPFLGY
VIPPSLNDALYWFGYLNSALNPMVYAFFYPWFRRALKMVLLGKIFQKDSSRSKLF--
>80:P53452 D(1)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=d14 PE=3 SV=1 2 259 7e-82 1 94.7% 29.3% 14:334 3:358
-------------QNFSTVGDGKQMLLERDSSKRVLTGCFLSLLIFTTLLGNTLVCVAVTKFRHLRsvTN
FFVISLAISDLLVAILVMPWKAATEIMGFWPFGEF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKVACLMISVAWTLSVLISFIPVQLNWHKAQTASYVELNGTYanCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCEa
cISSTTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSILLGCHRLCPGNSAIEI---
>81:Q5QD29 Trace amine-associated receptor 1 OS=Pan troglodytes OX=9598 GN=TAAR1 PE=3 SV=1 2 254 1e-81 1 95.8% 39.9% 15:337 3:336
--------------PFCHNinISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISHFKELHTPTN
WLIHSMATVDFLPGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPL
RYKAKINILVICVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLTftSFYI
PGSIMLCVYYRIYLIAKEQARLINDANQKLQIGLEmeRKAVKTLGIVMGVFLICWCPFFICTVMDPFLHY
IIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMMLFGKIFQKDSSRCKLFLE
>82:P97292 Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 2 255 3e-81 1 89.3% 33.4% 30:334 14:316
-----------------------------SIALKVTISVVLTTLIFITVAGNVVVCLAVSLNRRLRSLTN
CFIVSLAATDLLLGLLVMPFSAIYQLSFKWSFGQVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPL
RYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGND---TFKCKVQVNEVYGLVdmVTFYL
PLLIMCVTYYRIFKIAREQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIVCWFPYFTAFVYRGlgDD
AVNEVVEGIVLWLGYANSALNPILYATLNRDFRMAYQQLFHCKLASHNSHKTSL---
>83:Q62758 5-hydroxytryptamine receptor 4 OS=Rattus norvegicus OX=10116 GN=Htr4 PE=2 SV=1 2 255 3e-81 1 88.7% 34.1% 34:332 19:339
---------------------------------KVVLLTFFAMVILMAILGNLLVMVAVCRDRQLRKitN
YFIVSLAFADLLVSVLVNAFGAIELVQDIWFYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAIcqPL
VYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDVIehNSNSTFCVFMVNKPYAItsVVAFYI
PFLLMVLAYYRIYVTAKEHAQQIQMLqqHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDPFIDY
TVPEKVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYKRPPI-----
>84:P25100 Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 2 260 5e-81 1 89.9% 31.3% 7:316 67:413
------SSAGEPGSAGAgdVNGTAAVGGLVVSAqvGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTN
YFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSL
KYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVP----PDERFCGITEEAGYAVF---SSVCSFYL
PMAVIVVMYCRVYVVARStaDGAHGMRSAKGHTFrrEKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQ
LKpeGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>85:P08588 Beta-1 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB1 PE=1 SV=2 2 257 5e-81 1 89.3% 32.7% 3:317 40:388
--ASLLPPASESPEPLSQQWTAG-------------MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRE
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQ--------------------
>86:P47800 D(1)-like dopamine receptor OS=Oreochromis mossambicus OX=8127 PE=2 SV=1 2 252 3e-80 1 95.8% 29.1% 8:337 9:357
-------GTSAGPEPAPGGHGGTDSPRTSDLSLRALTGCVLCILIVSTLLGNALVCAAVIKFRHLRsvTN
AFVISLAVSDLFVAVLVMPWRAVSEVAGVWLFGAF-CDTWVAFDIMCSTASILHLCIISMDRYWAISSPF
RYERRMTPRFGCVMIGVAWTLSVLISFIPVQLNWHARG-----RERTDPGDCNASLNRTYAisSLISFYI
PVLIMVGTYTRIFRIGRTQIRRISSLErsLKTSFRRETKVLKTLSVIMGVFVFCWLPFFVLNCMVPFCRl
cVSDTTFSVFVWFGWANSSLNPVIYAF-NADFRKAFSTILGCSRYCRTseAVDFSNE
>87:P34971 Beta-1 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb1 PE=1 SV=2 2 254 4e-80 1 79.8% 34.4% 51:320 75:380
--------------------------------------------------GNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLL-----------------
>88:P21918 D(1B) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD5 PE=1 SV=2 2 254 5e-80 1 90.2% 31.7% 32:337 38:392
-------------------------------PSQVVTACLLTLLIIWTLLGNVLVCAAIVRSRHLrnMTN
VFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAF-CDVWVAFDIMCSTASILNLCVISVDRYWAISRPF
RYKRKMTQRMALVMVGLAWTLSILISFIPVQLNWHRDQAASWgePDVNAENCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAQVQIRRISSLErsLRASIKKETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCSg
cVSETTFDVFVWFGWANSSLNPVIYAF-NADFQKVFAQLLGCSHFCSRTptVNISNE
>89:Q923Y9 Trace amine-associated receptor 1 OS=Rattus norvegicus OX=10116 GN=Taar1 PE=2 SV=1 2 249 7e-80 1 94.4% 38.7% 18:335 6:331
-----------------NSANISHTNSNWSRDVRASLYSLISLIILTTLVGNLIVIISISHFKQLHTPTN
WLLHSMAVVDFLLGCLVMPYSMVRTVEHCWYFGELFCKLHTSTDIMLSSASILHLAFISIDRYYAVCDPL
RYKAKINLAAIFVMILISWSLPAVFAFGMIFLELNLEGVEeyHNQVFCLRGCFPFFSKVSGVLAftSFYI
PGSVMLFVYYRIYFIAKGQARSINrlEGESRAPQSKETKAAKTLGIMVGVFLLCWCPFFFCMVLDPFLGY
VIPPTLNDTLNWFGYLNSAFNPMVYAFFYPWFRRALKMVLFGKIFQKDSSRSKLF--
>90:P41596 Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 2 255 8e-80 1 91.1% 28.3% 30:336 139:478
-----------------------------SLVSIVVVGIFLSVLIFLSVAGNILVCLAIYTERSLRRIGN
LFLASLAIADLFVASLVMTFAGVNDLLGYWIFGAQFCDTWVAFDVMCSTASILNLCAISMDRYIHIKDPL
RYGRWVTRRVAVITIAAIWLLAAFVSFVPISLGIHRPDQPLIFEDNgkYPTCALDLTPTYAVvsCISFYF
PCVVMIGIYCRLYCYAQKHVKSirNLHTHSSPYHVSDHKAAVTVGVIMGVFLICWVPFFCVNITAAFCKT
CIGGQTFKILTWLGYSNSAFNPIIYSIFNKEFRDAFKRILtrNPWCCAQDVGNIHP-
>91:Q9P1P4 Putative trace amine-associated receptor 3 OS=Homo sapiens OX=9606 GN=TAAR3P PE=5 SV=1 2 249 9e-80 1 85.8% 43.3% 49:337 46:341
------------------------------------------------LFGNLVIMVSISHFKQLHSPTN
FLILSMATTDFLLGFVIMPYSIMRSVESCWYFGDGFCKFHTSFDMMLRLTSIFHLCSIAIDRFYAVCYPL
HYTTKMTNSTIKQLLAFCWSVPALFSFGLVLSEADVSGMQSYKILVACFNFCALTFNKFWGTILftCFFT
PGSIMVGIYGKIFIVSKQHARVISHVPEnkHLSKKKDRKAAKTLGIVMGVFLACWLPCFLAVLIDPYLDY
STPILILDLLVWLRYFNSTCNPLIHGFFNPWFQKAFKYIVSGKIFSSHSETANLFPE
>92:P47899 Beta-1 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB1 PE=3 SV=1 2 254 1e-79 1 89.3% 32.4% 3:317 40:391
--ASLLPPASEGPEPLSQQWTAG-------------MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPF
RYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGParEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRE
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRNAFQ--------------------
>93:P18090 Beta-1 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb1 PE=1 SV=1 2 253 1e-79 1 79.8% 34.1% 51:320 75:380
--------------------------------------------------GNVLVIVAIAKTPRLQTLTN
LFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITLPF
RYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAisSVVSFYV
PLCIMAFVYLRVFREAQKQVKKIDSCERRFLTGPprEQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRD
LVPDRLFVFFNWLGYANSAFNPIIYC-RSPDFRKAFQRLL-----------------
>94:P42289 D(1A) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1 PE=2 SV=1 2 252 3e-79 1 89.6% 31.9% 26:329 14:357
-------------------------LTERESSFRVLTGCFLSVLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGTF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKVAFIMIGVAWTLSVLISFIPVQLNWHKAKTTSFFdhDRTMDNCDSSLNRTYAisSLISFYI
PVAIMIVTYTRIYRIAAKQIRRISALErsLKTSFKRETKVLKTLSVIMGVFVCCWLPFFILNCIVPFCdf
CISSTTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSNLLGCYRLCPTS--------
>95:P25962 Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2 2 248 2e-78 1 89.3% 32.5% 20:321 20:358
-------------------LDPSAANTSGLPGVPWAAALAGALLALATVGGNLLVIIAIARTPRLQTITN
VFVTSLAAADLVVGLLVMPPGATLALTGHWPLGETGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGTLVTKRRARAAVVLVWIVSAAVSFAPIMSQWWRVGADAEAQEChnPRCCSFASNMPYALlsSVSFYL
PLLVMLFVYARVFVVAKRQRHLLRRerRPARLLPLREHRALRTLGLIMGIFSLCWLPFFLANVLRALAgs
LVPSGVFIALNWLGYANSAFNPVIYC-RSPDFRDAFRRLLC----------------
>96:P60021 Histamine H2 receptor OS=Pan troglodytes OX=9598 GN=HRH2 PE=3 SV=1 2 246 3e-78 1 89.6% 33.4% 30:334 14:317
-----------------------------STACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTN
CFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPL
RYPVLVTPVRVAISLVLIWVISITLS--FLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVdlVTFYL
PLLIMCITYYRIFKVARDQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGlgDD
AINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSL---
>97:P61752 Histamine H2 receptor OS=Pongo pygmaeus OX=9600 GN=HRH2 PE=3 SV=1 2 246 3e-78 1 89.6% 33.4% 30:334 14:317
-----------------------------STACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTN
CFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPL
RYPVLVTPVRVAISLVLIWVISITLS--FLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVdlVTFYL
PLLIMCITYYRIFKVARDQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGlgDD
AINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSL---
>98:Q76MS7 Histamine H2 receptor OS=Gorilla gorilla gorilla OX=9595 GN=HRH2 PE=3 SV=1 2 246 3e-78 1 89.6% 33.4% 30:334 14:317
-----------------------------STACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTN
CFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPL
RYPVLVTPVRVAISLVLIWVISITLS--FLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVdlVTFYL
PLLIMCITYYRIFKVARDQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGlgDD
AINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSL---
>99:P25021 Histamine H2 receptor OS=Homo sapiens OX=9606 GN=HRH2 PE=2 SV=1 2 246 3e-78 1 89.6% 33.4% 30:334 14:317
-----------------------------STACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTN
CFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPL
RYPVLVTPVRVAISLVLIWVISITLS--FLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVdlVTFYL
PLLIMCITYYRIFKVARDQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGlgDD
AINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSL---
>100:P25102 Histamine H2 receptor OS=Rattus norvegicus OX=10116 GN=Hrh2 PE=3 SV=1 2 245 1e-77 1 89.3% 33.4% 30:334 14:316
-----------------------------SMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTN
CFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPL
RYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGND---TFKCKVQVNEVYGLVdlVTFYL
PLLIMCVTYYRIFKIAREQAKRINHIS-SWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGlgDD
AINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSL---
>101:Q4LBB9 Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2 2 250 1e-77 1 85.8% 32.1% 33:322 152:482
--------------------------------VWVFKAFVMLLIIIAAICGNLLVIISVMRVRKLRVITN
YFVVSLAMADIMVAIMAMTFNFSVQVTGRWNFSPFLCDLWNSLDVYFSTASILHLCCISVDRYYAIVKPL
KYPISMTKRVVGIMLLNTWISPALLSFLPIFIGWYTTPQHQQF-VIQNPTQCSFVVNKYYAVisSISFWI
PCTIMIFTYLAIFREANRQEKQLMMRHGNAMLMHRpeHKAARTLGIIMGTFILCWLPFFLWYTLSMTCEE
cvPDIVVSILFWIGYFNSTLNPLIYAYFNRDFREAFRNTLLC---------------
>102:G3M4F8 Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 2 245 1e-77 1 86.4% 34.4% 38:331 41:364
-------------------------------------TCVLLLIVIMAVLGNMLVIVSVMRHRKLRVITN
YFVVSLAFADILVAMVVMPFNFSVQFNQGWVFGETICDLWNSSDVYFTSTSILHLCCISVDRYYAIVKPL
KYPIKMTKKMAFVMLAATWLSPITISYVPIFMGWYTTTDFL---ESRRDDQCEFKVNKPYAVISsiSFWI
PCTIMIFTYLAIFKEANRQEKALHARAGNAMLMHRheHKAARTLGIIMGAFILCWLPFFLYYVSTSLCDS
CNCPEVVTVifWTGYFNSALNPIIYAYFNRDFRNAFKNTLAccSFCKRSAS------
>103:O77680 D(1A) dopamine receptor OS=Macaca mulatta OX=9544 GN=DRD1 PE=3 SV=1 2 247 2e-77 1 93.2% 30.1% 14:329 3:354
-------------TLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGneTIDNCDSSLSRTYAisSVISFYI
PVAIMIVTYTRIYRIAQKQIRRIAALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCgf
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPAT--------
>104:P42288 D(1A) dopamine receptor OS=Didelphis virginiana OX=9267 GN=DRD1 PE=2 SV=1 2 247 2e-77 1 81.6% 32.1% 51:327 39:355
--------------------------------------------------GNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKAAFILISVAWTLSVLISFIPVQLNwlSSPDGNVSSQDETMDNCDSSLSRTYAisSLISFYI
PVAIMIVTYTRIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVPFcpF
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCP----------
>105:Q9TST4 Beta-3 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB3 PE=3 SV=1 2 245 2e-77 1 83.1% 32.7% 48:328 51:368
-----------------------------------------------TVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRCHSNPHCCAFASnyALLSSSVSFYL
PLLVMLFVYARVFVVATRQLRLLRGerRPARLLPLREHRALRTLGLIMGTFSLCWLPFFVANVVRALGgs
LVPSPAFLALNWLGYANSAFNPLIYC-RSPDFRSAFRRLLCRCRLEER---------
>106:Q95136 D(1A) dopamine receptor OS=Bos taurus OX=9913 GN=DRD1 PE=2 SV=2 2 246 3e-77 1 93.2% 30.4% 14:329 3:354
-------------TLNTSTMEGTGLVAERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTGPSEGNatINNCDSSLSRTYAisSLISFYI
PVAIMIVTYTRIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCgf
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPTT--------
>107:P21728 D(1A) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD1 PE=1 SV=1 2 246 4e-77 1 93.2% 30.1% 14:329 3:354
-------------TLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGneTIDNCDSSLSRTYAisSVISFYI
PVAIMIVTYTRIYRIAQKQIRRIAALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCgf
CIDSNTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPAT--------
>108:Q588Y6 5-hydroxytryptamine receptor 1B OS=Felis catus OX=9685 GN=HTR1B PE=2 SV=1 2 244 5e-77 1 85.5% 33.0% 31:324 45:387
------------------------------LPWKVLLILVLALFTLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSDCRVNTDHMLYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>109:P50130 D(1A) dopamine receptor OS=Sus scrofa OX=9823 GN=DRD1 PE=3 SV=1 2 245 7e-77 1 93.2% 29.7% 14:329 3:354
-------------TLNTSTMDGTGLVVERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNvtTHNCDSSLSRTYAisSLISFYI
PVAIMIVTYTRIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCgf
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPTS--------
>110:P35406 D(1) dopamine receptor OS=Carassius auratus OX=7957 PE=2 SV=1 2 242 9e-77 1 89.0% 32.5% 32:333 22:356
-------------------------------SVRVLTGCFLSVLILSTLLGNTLVCAAVTKFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVTEVAGFWPFGAF-CDIWVAFDIMCSTASILNLCVISVDRYWAISSPF
RYERKMTPRVAFVMISGAWTLSVLISFIPVQLKWHKAQPIGFLedLPTDNCDSSLNRTYAISSSLISFYI
PVAIMIVTYTQIYRIAQKQIRRimDLESSFKLSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCKr
cISPTTFDVFVWFGWANSSLNPIIYAF-NADFRRAFAILLGCQRLCPGSISME----
>111:P28222 5-hydroxytryptamine receptor 1B OS=Homo sapiens OX=9606 GN=HTR1B PE=1 SV=1 2 243 1e-76 1 93.2% 31.4% 2:326 22:390
-QANLSSAPSQNCSAKDYIYQDSI-----SLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSECVVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS-----------
>112:P60020 5-hydroxytryptamine receptor 1B OS=Pan troglodytes OX=9598 GN=HTR1B PE=3 SV=1 2 243 1e-76 1 93.2% 31.4% 2:326 22:390
-QANLSSAPSQNCSAKDYIYQDSI-----SLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSECVVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS-----------
>113:P42291 D(1C) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1c PE=2 SV=1 2 245 1e-76 1 81.3% 32.6% 52:327 46:349
---------------------------------------------------NTLVCLAVIKFRHLRsvTN
FFVISLAVSDLFVALLVMPWKAVTEVAGFWVFGDF-CDTWVAFDIMCSTASILNLCIISLDRYWAIASPF
RYERKMTQRVAFIMIGVAWTLSILISFIPvlSWHKSHEADEELNGVNHTENCDSSLNRTYAisSLISFYI
PVVIMIGTYTRIYRIAQTQIRRISSLERAVEHAQRceTKVLKTLSIIMGVFVFCWLPFFVLNCMIPFCHm
cVSETTFNIFVWFGWANSSLNPVIYAF-NADFRKAFTTILGCNRFCS----------
>114:P35404 5-hydroxytryptamine receptor 1B OS=Didelphis virginiana OX=9267 GN=HTR1B PE=2 SV=1 2 242 2e-76 1 91.7% 31.0% 8:323 22:385
-------NHSTFPNPNCSAPDLEPYQDSIALPWKVLLATFLGLITLGTTLSNAFVIATVSRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAGMIIMVWVFSVSISMPPLF-------WRQAKAEEVADCSVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATRTLGIILGAFIVCWLPFFIISLALPICdc
WFHLAIFDFFNWLGYLNSLINPIIYTKSNDDFKQAFQKLMRFR--------------
>115:P23944 Alpha-1D adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1d PE=2 SV=2 2 247 2e-76 1 89.9% 32.9% 7:316 62:407
------SSTGEPGAAASGEVNGSAAVGGLVVSAqvGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTN
YFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSL
KYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVP----PDERFCGITEEVGYAIF---SSVCSFYL
PMAVIVVMYCRVYVVARsqSSKGHTLRSSLSVRlsREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQ
LKpeGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>116:Q60484 5-hydroxytryptamine receptor 1D OS=Cavia porcellus OX=10141 GN=HTR1D PE=3 SV=1 2 242 2e-76 1 84.9% 34.6% 32:323 36:373
-------------------------------ALKVSLVVVLSIITLATVLSNAFVLTTILLTRKLHTPAN
YLIGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGHAGAMIAAVWVISICISIPPLF---WRQAQAQEEMSDCLVNTSQISYT---IYSTCGAFYI
PSVLLIILYSRIYRAARSRILNPPSLSGKRFTTAhrERKATKTLGIILGAFIVCWLPFFVVSLVLPICrc
WIHPALFDFFTWLGYLNSLINPIIYTVFNEDFRQAFQKVVHFR--------------
>117:Q9N2B7 5-hydroxytryptamine receptor 1B OS=Gorilla gorilla gorilla OX=9595 GN=HTR1B PE=3 SV=1 2 242 2e-76 1 93.2% 31.4% 2:326 22:390
-QANLSSAPSQNCSAKDYIYQDSI-----ALPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSECVVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS-----------
>118:P17124 Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1 2 241 3e-76 1 89.6% 31.5% 30:334 14:317
-----------------------------SPPCRITVSVVLTVLILITIAGNVVVCLAVGLNRRLRSLTN
CFIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPL
RYPVLITPVRVAVSLVLIWVISITLS--FLSIHLGWNSRNETSSFNHTIPKCKVQVNLVYGLVdlVTFYL
PLLVMCITYYRIFKIARDQAKRIHHM-GSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGD
DAINEAFevVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHNAQETSL---
>119:P28221 5-hydroxytryptamine receptor 1D OS=Homo sapiens OX=9606 GN=HTR1D PE=1 SV=1 2 240 1e-75 1 93.2% 31.6% 1:320 1:371
MSPLNQSAEGLPQEASNRSLNATETSEAWDpaLKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPAN
YLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGHAATMIAIVWAISICISIPPLF---WRQAKAQEEMSDCLVNTSQISYT---IYSTCGAFYI
PSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAhrERKATKILGIILGAFIICWLPFFVVSLVLPICrc
WIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIV-----------------
>120:Q9TTM9 Alpha-1D adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRA1D PE=3 SV=1 2 245 2e-75 1 84.9% 32.1% 32:324 93:421
-------------------------------AQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTN
YFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSL
KYPSIMTERKAAAILALLWAVAIVVSVGPLLGWKEPVP----PDERFCGITEEAGYAVF---SSLCSFYL
PMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKasREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQ
LKpeGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQC-------------
>121:Q61616 D(1A) dopamine receptor OS=Mus musculus OX=10090 GN=Drd1 PE=1 SV=2 2 242 2e-75 1 93.2% 29.7% 14:329 2:354
-------------APNTSTMDETGLPVERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
QYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHkdGNFTSLEDAEDDNCDTRLSRTYAISSSLISFYI
PVAIMIVTYTSIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFISNCMVPFCgf
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFQKAFSTLLGCYRLCPTT--------
>122:P49145 5-hydroxytryptamine receptor 1D OS=Oryctolagus cuniculus OX=9986 GN=HTR1D PE=3 SV=1 2 239 2e-75 1 93.5% 30.7% 1:323 1:374
MSPSNQSAEGLPQEAANRSLNATGTPEAWDpaLKISLAVVLSIITVATVLSNTFVLTTILLTRKLHTPAN
YLIGSLATTDLLVSILVMPISIAYTITHTWNFGQVLCDIWVSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGHAAAMIAVVWAISICISIPPLFWRQAKA--------HEEVSDCLVNTSqyTIYSTCGAFYI
PSVLLIVLYGRIYMAARNRILNPPSLYGKRFTTAhrERKATKTLGIILGAFIGCWLPFFVASLVLPICrc
WMPPGLFDFFTWLGYLNSLINPIIYTVFNEDFRQAFQRVIHFR--------------
>123:P18901 D(1A) dopamine receptor OS=Rattus norvegicus OX=10116 GN=Drd1 PE=1 SV=2 2 241 3e-75 1 82.2% 31.9% 51:329 39:354
--------------------------------------------------GNTLVCAAVIRFRHLRsvTN
FFVISLAVSDLLVAVLVMPWKAVAEIAGFWPLGPF-CNIWVAFDIMCSTASILNLCVISVDRYWAISSPF
QYERKMTPKAAFILISVAWTLSVLISFIPVQLSwwPLDGNFTSLEDTEDDNCDTRLSRTYAisSLISFYI
PVAIMIVTYTSIYRIAQKQIRRISALErsFKMSFKRETKVLKTLSVIMGVFVCCWLPFFISNCMVPFCgf
CIDSITFDVFVWFGWANSSLNPIIYAF-NADFQKAFSTLLGCYRLCPTT--------
>124:P11614 5-hydroxytryptamine receptor 1D OS=Canis lupus familiaris OX=9615 GN=HTR1D PE=2 SV=1 2 238 7e-75 1 84.3% 33.8% 32:321 36:372
-------------------------------ALKISLALLLSIITMATALSNAFVLTTIFLTRKLHTPAN
YLIGSLAMTDLLVSILVMPISIAYTTTRTWSFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGRAAVMIATVWVISICISIPPLF---WRQAKAQEDMSDCQVNTSQISYT---IYSTCGAFYI
PSVLLIILYGRIYVAARNRILNPPSLYGKRFTTAqrERKATKTLGIILGAFIVCWLPFFVASLVLPICrc
WLHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQRVVH----------------
>125:Q8UUY8 Beta-2 adrenergic receptor OS=Oncorhynchus mykiss OX=8022 GN=adrb2 PE=2 SV=1 2 239 8e-75 1 87.2% 32.9% 27:321 29:349
--------------------------SEYSEAVAVLLGILMALLVMCIVFGNVLVITAIVRFQRLQTVTN
MFITSLACADLVMGLLVVPFGACYILLNTWHFGSFLCEFWTAADVLCVTASIETLCVIALDRYLAITSPL
RYPSLLTKRKACVVVVTVWGVAALISFLPIHMKWWVSDEPEALSCLEDAHCCDFNTNAAYAvsSVVSFYI
PLAVMAFVYGRVFQEARKQLEKIRGSEGRFHAQMIdeHKALKTLGIIMGTFTLCWLPFFVLNVVVTIWKV
DNIKMPFRILNWIGYANSAFNPLIYC-RSPEFRYAFQEILC----------------
>126:P97714 Alpha-1D adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1d PE=2 SV=1 2 243 1e-74 1 91.4% 33.3% 2:316 49:407
-SAVVGTGSGEDNQSSTAevNGSAAVGGLVVSAqvGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTN
YFIVNLAVADLLLSAAVLPFSATMEVLGFWPFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSL
KYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVP----PDERFCGITEEVGYAIF---SSVCSFYL
PMAVIVVMYCRVYVVARsqSSKGHTLRSSLSVRlsREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQ
LKpeGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>127:P11617 Adenosine receptor A2a OS=Canis lupus familiaris OX=9615 GN=ADORA2A PE=2 SV=1 2 238 1e-74 1 87.2% 28.4% 35:330 7:313
----------------------------------WVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTN
YFVVSLAAADIAVGVLAIPFAITISTGFC--AACHNCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPL
RYNGLVTGTRAKGIIAVCWVLSFalTPMLGWNNCSQPKEGRNYSQGCGEGQVACLFenYMVYYNFFAflV
PLLLMLGVYLRIFLAARRQLKQMESQpeRARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPE
CspLWLMYLTIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRRREP-------
>128:Q0EAB5 5-hydroxytryptamine receptor 1B OS=Equus caballus OX=9796 GN=HTR1B PE=2 SV=1 2 237 2e-74 1 91.1% 31.8% 13:326 29:390
------------PSHNCS-TEGYVYQDSVALPWKVLLVVLLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYVVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVLDCLVNTDHILYTVYSTVGAFYF
PTLLLIALYSRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCAS-----------
>129:O08892 5-hydroxytryptamine receptor 1B OS=Cavia porcellus OX=10141 GN=HTR1B PE=3 SV=1 2 237 3e-74 1 93.8% 32.3% 3:324 12:387
--AVLGSQTGLPHAnsAPPNNCSAPSHIyaLPWKVLLVVLLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAFTDLLVSILVMPISTMYTVTGRWTLGQALCDFWLSSDITCCTASIMHLCVIALDRYWAITDAV
GYSAKRTPRRAAGMIALVWVFSICISLPPFFWRQAK------AEEEVLDCLVNTDHVLYTVYSTGGAFYL
PTLLLIALYGRIYVEARSRILKQTPNkeKKKLMAARERKATKTLGVILGAFIVCWLPFFIISLVMPIcaC
WFHMAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>130:Q6XXX8 5-hydroxytryptamine receptor 1B OS=Vulpes vulpes OX=9627 GN=HTR1B PE=3 SV=1 2 237 4e-74 1 79.8% 33.5% 52:326 66:389
---------------------------------------------------NAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYAVTGRWTLGQVVCDLWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSDCVVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCAS-----------
>131:Q28524 Beta-3 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB3 PE=2 SV=1 2 237 4e-74 1 83.7% 33.9% 48:330 51:371
-----------------------------------------------TVGGNLLVIVAITRTPRLQTMTN
VFVTSLAAADLVMGLLVVPPAATLVLTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASnyVLLSSSVSFYL
PLLVMLFVYARVFVVATRQLRLlpALSRSLAPAParEHRALCTLGLIMGTFTLCWLPFFLANVLRALGgs
LVPDPAFLALNWLGYANSAFNPLIYC-RSPDFRSAFRRLLccGGRLPREP-------
>132:P79250 5-hydroxytryptamine receptor 1B OS=Canis lupus familiaris OX=9615 GN=HTR1B PE=2 SV=2 2 236 6e-74 1 92.6% 31.1% 7:324 21:387
------PPANLSSAPHNCSAEGYIYQDSVALPWKVLLVILLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDLWLSSDITCCTASILHLCVIALDRYWAITDAV
EYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAK------AEEEVSDCVVNTDHILYTVYSTVGAFYF
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>133:P29274 Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2 2 237 7e-74 1 88.1% 28.7% 31:330 4:313
------------------------------MGSSVYITVELAIAVL-AILGNVLVCWAVWLNSNLQNVTN
YFVVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPL
RYNGLVTGTRAKGIIAICWVLSFalTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFenYMVYFNFFAclV
PLLLMLGVYLRIFLAARRQLKQMESQpeRARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPD
CspLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEP-------
>134:P26255 Beta-3 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb3 PE=2 SV=2 2 236 8e-74 1 93.8% 31.2% 20:336 20:374
-------------------LDPSAANTSGLPGVPWAAALAGALLALATVGGNLLVITAIARTPRLQTITN
VFVTSLATADLVVGLLVMPPGATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGTLVTKRRARAAVVLVWIVSATVSFAPIMSQWWRVGADAEAQEChnPRCCSFASNMPYALlsSVSFYL
PLLVMLFVYARVFVVAKRQRRLLRRerRPARLLPLGEHRALRTLGLIMGIFSLCWLPFFLANVLRALVgs
LVPSGVFIALNWLGYANSAFNPLIYC-RSPDFRDAFRRLLCSYGGrpEEPRVVTFP-
>135:P34969 5-hydroxytryptamine receptor 7 OS=Homo sapiens OX=9606 GN=HTR7 PE=1 SV=2 2 238 1e-73 1 89.0% 30.8% 19:326 66:405
------------------NASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSN
YLIVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPL
TYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVN-----DDKVCLISQDFGYT---IYSTAVAFYI
PMSVMLFMYYQIYKAARKSAAKHKfhERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLsfICGTSCS
CIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRN-----------
>136:P50407 5-hydroxytryptamine receptor 7 OS=Cavia porcellus OX=10141 GN=HTR7 PE=2 SV=1 2 237 2e-73 1 89.0% 31.2% 19:326 67:406
------------------NVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSN
YLIVSLALADLSVAVAVIPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPL
TYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVN-----DDKVCLISQDFGYT---IYSTAVAFYI
PMSVMLFMYYRIYKAARKSAAKHKfhERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLsfICGTACS
CIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRN-----------
>137:P32305 5-hydroxytryptamine receptor 7 OS=Rattus norvegicus OX=10116 GN=Htr7 PE=2 SV=2 2 236 2e-73 1 89.0% 30.8% 19:326 69:408
------------------NVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSN
YLIVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPL
TYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVN-----DDKVCLISQDFGYT---IYSTAVAFYI
PMSVMLFMYYQIYKAARKSAAKHKfhERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLsfICGTSCS
CIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRN-----------
>138:P49144 5-hydroxytryptamine receptor 1B OS=Oryctolagus cuniculus OX=9986 GN=HTR1B PE=2 SV=1 2 234 2e-73 1 79.8% 33.8% 52:326 67:390
---------------------------------------------------NAFVVATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDLWLSSDITCCTASIMHLCVIALDRYWAITDAV
EYSAKRTPKRAAIMIRLVWVFSICISLPPFFWRQAK------AEEEVSECLVNTDHVLYTVYSTVGAFYL
PTLLLIALYGRIYVEARSRILKQTPNreKKKLMAARERKATKTLGIILGVFIVCWLPFFIISLVMPIcaC
WFHQAIFDFFTWLGYVNSLINPIIYTMSNEDFKQAFHKLIRFKCTS-----------
>139:Q95252 Beta-3 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB3 PE=2 SV=2 2 235 3e-73 1 90.2% 31.5% 19:323 22:363
------------------PNNANTSGLPGVPWAVALAGALLAPAVLATVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGTTLALTGHWPLGATCCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRCHSNPSCCTFASnyALLSSSVSFYL
PLLVMLFVYARVFVVATSQLRLLrhGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFVVNVVRALGgs
LVPVPAFLALNWLGYANSAFNPLIYC-HSPDFRSAFRRLLCRC--------------
>140:P32304 5-hydroxytryptamine receptor 7 OS=Mus musculus OX=10090 GN=Htr7 PE=2 SV=2 2 235 4e-73 1 89.0% 30.8% 19:326 69:408
------------------NVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSN
YLIVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPL
TYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVN-----DDKVCLISQDFGYT---IYSTAVAFYI
PMSVMLFMYYQIYKAARKSAAKHKfhERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLsfICGTSCS
CIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRN-----------
>141:Q4R1I4 Melanopsin OS=Branchiostoma belcheri OX=7741 GN=OPN4 PE=1 SV=1 2 242 4e-73 1 93.5% 27.7% 5:322 45:385
----LLSGEGdtPTPGCTGNGSVCNGTDspLAHYIVGTAVFCIGC-CGMFGNAVVVYSFIKSKGLRTPAN
FFIINLALSDFLMNLTNMPIFAVNSAFQRWLLSDFACELYGFAGGLFGCLSINTLMAISMDRYLVITKPF
LVMRIVTKQRVMFAILLLWIWSLVwpPLFGWSAYVSEGFGTSCTFD--YMTPKLSYHIFTYIIFFTMYFI
PGGVMIYCYYNIFATVKsmAHEDVKNKAQQERQRKNEIKTAKIAFIVISLFMSAWTPYAVVSALGTlyQD
LVTPYLQSIPAMFAKSSAVYSPIVYAITYPKFREAVKKHIPC---------------
>142:Q9XT58 Beta-3 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB3 PE=3 SV=2 2 234 4e-73 1 81.9% 32.5% 48:324 51:364
-----------------------------------------------TVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRChnPRCCTFASNMPYALlsSVSFYL
PLLVMLFVYARVFVVAtsPAGVPSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRALGgs
LVSGPTFLALNWLGYANSAFNPLIYC-RSPDFRSAFRRLLCRCP-------------
>143:P28564 5-hydroxytryptamine receptor 1B OS=Rattus norvegicus OX=10116 GN=Htr1b PE=2 SV=1 2 234 5e-73 1 79.2% 33.3% 52:324 63:384
---------------------------------------------------NAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAV
DYSAKRTPKRAAIMIVLVWVFSISISLPPFFWRQAK------AEEEVLDCFVNTDHVLYTVYSTVGAFYL
PTLLLIALYGRIYVEARSRILKQTPNkeKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHMAIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>144:Q6TLI7 Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1 2 234 6e-73 1 88.7% 28.6% 30:330 2:313
-----------------------------PTVGSLVYIMVELAIALLAILGNMLVCWAVWLNSNLQNVTN
YFVVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPL
RYNGLVTGTRAKGVIAVCWVLSFalTPMLGWNNCHHWGEGENQSQGCGEGQVACLfnYMVYYNFFACVLV
PLLLMLGVYLRIFLAARRQLKQMETQpeRARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPE
caPLWLMYPAIILSHFNSVVNPFIYAYRIREFRHTFHKIIRSHILRRQEP-------
>145:P56496 5-hydroxytryptamine receptor 1B OS=Spalax ehrenbergi OX=30637 GN=HTR1B PE=3 SV=1 2 233 6e-73 1 92.6% 31.4% 7:324 12:384
------PPAGSQTQTPSSNLSHNCSADSyaLPWKVLLVALLALITLATTLSNAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAV
EYSAKRTPRRAAVMIALVWVFSISISLPRFFWRQAK------AEEEVLDCLVNTDHVLYTVYSTVGAFYL
PTLLLIALYGRIYVEARSRILKQTPNkeKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHMAIFDFFNWLGYLNSLINPIIYTMPNEDFKQAFHKLIRFKC-------------
>146:P28334 5-hydroxytryptamine receptor 1B OS=Mus musculus OX=10090 GN=Htr1b PE=2 SV=1 2 233 7e-73 1 79.2% 33.3% 52:324 63:384
---------------------------------------------------NAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAV
EYSAKRTPKRAAIMIVLVWVFSISISLPPFFWRQAKAEE----EMLDCFVNTDHVL--YTVYSTVGAFYL
PTLLLIALYGRIYVEARSRILKQTPNkeKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHMAIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>147:F1MV99 Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2 2 232 1e-72 1 90.2% 25.3% 2:321 16:322
-SSVVPSGSGDENGTLAG-------LGPSPGARAVVVPVLYLLVCAVGLGGNTLVIYVVLRHAKMKTVTN
IYILNLAVADVLL-MLGLPFVATQNAISYWPFGPVLCRLVMTLDGINQFTSIFCLTVMSVDRYLAVVHPI
RSARWRRPRVAKLASAAVWAFSLVMSLPLVVFADIQEGWNTCNLSWPEP--VGLWGAVFIIYTSVLGFFG
PLLVICLCYLLIVVKLKASGVRVGSTRR------RSERKVTRMVVVVVLVFAGCWLPFFIVNIVNLAFAL
PEEPaaYFFVVVLSYANSCANPLLYGFLSDNFRQSFRKVLC----------------
>148:O02666 Alpha-1D adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1D PE=2 SV=1 2 238 1e-72 1 82.5% 31.9% 32:316 99:418
-------------------------------AQSVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTN
YFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSL
KYPAIMTERKAAAILALLWAVALVVSMGPLLGWKEPVP----PDERFCGITEEVGYAVF---SSLCSFYL
PMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKasREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQ
LKpeGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>149:P47747 Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1 2 231 1e-72 1 83.4% 33.5% 51:334 35:317
--------------------------------------------------GNVVVCLAVGLNRRLRSLTN
CFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPL
RYPVLITPARVAISLVFIWVISITLS--FLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVdlVTFYL
PLLIMCITYFRIFKIAREQARRINHI-GSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGD
DAVNEVfdVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSL---
>150:P46636 5-hydroxytryptamine receptor 1B OS=Cricetulus griseus OX=10029 GN=HTR1B PE=2 SV=1 2 232 2e-72 1 79.2% 32.6% 52:324 63:384
---------------------------------------------------NAFVIATVYRTRKLHTPAN
YLIASLAVTDLLVSILVMPVSTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAV
EYAAKRTPKRAAIMIALVWVFSISISLPPFFWRQAK------AEEEVLTCLVNTDHVLYTVYSTGGAFYL
PTLLLIALYGRIYVEARSRILKQTPNkeKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPIcaC
WFHMATLDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>151:P25931 RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2 2 234 3e-72 1 92.3% 24.9% 16:328 87:406
---------------SCDDYDLLSEDMWSSAYFKIIVYMLYIPIFIFALIGNGTVCYIVYSTPRMRTVTN
YFIASLAIGDILMSFFCVPSSFISliLNYWPFGLALCHFVNYSQAVSVLVSAYTLVAISIDRYIAIMWPL
--KPRITKRYATFIIAGVWFIALATALPIPIVSGLDIPMSPwcEKYICREMWPSRTQEYYYTLSLFafVV
PLGVLIFTYARITIRVWAKRPPGEAETNRDQRMARSKRKMVKMMLTVVIVFTCCWLPFNILQLleEFAHW
DPLPYVWFAFHWLAMSHCCYNPIIYCYMNARFRSGFVQLMHRMPGLRR---------
>152:P35346 Somatostatin receptor type 5 OS=Homo sapiens OX=9606 GN=SSTR5 PE=1 SV=3 2 230 5e-72 1 78.3% 27.4% 48:321 54:320
-----------------------------------------------GLGGNTLVIYVVLRFAKMKTVTN
IYILNLAVADVLY-MLGLPFLATQNAASFWPFGPVLCRLVMTLDGVNQFTSVFCLTVMSVDRYLAVVHPL
SSARWRRPRVAKLASAAAWVLSLCMSLPLLVFADVQEGGTCNASWPEPVGLWGAVFIIYTA---VLGFFA
PLLVICLCYLLIVVKVRAAGVRVG------CVRRRSERKVTRMVLVVVLVFAGCWLPFFTVNIVNLAVAL
PQEPalYFFVVILSYANSCANPVLYGFLSDNFRQSFQKVLC----------------
>153:Q9XT57 Beta-3 adrenergic receptor OS=Capra hircus OX=9925 GN=ADRB3 PE=3 SV=1 2 231 8e-72 1 81.6% 31.9% 48:323 51:363
-----------------------------------------------IVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRChnPRCCTFASNMPYALlsSVSFYL
PLLVMLFVYARVFVVAtsPAGVPSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRALGgs
LVSGPTFLALNWLGYANSAFNPLIYC-RSPDFQSAFRRLLCRC--------------
>154:P41144 Kappa-type opioid receptor OS=Cavia porcellus OX=10141 GN=OPRK1 PE=2 SV=1 2 229 2e-71 1 92.0% 25.9% 2:317 19:342
-NACLLpgSAWLPGWAEPDGNGSAGPQDEQlaIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATN
IYIFNLALADALVT-TTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPV
KALDFRTPLKAKIINICIWLlsVGISAIILGGTKVREDVDIIECSLQFPDDDYSWWDLFMKICVFvaFVI
PVLIIIVCYTLMILRLKS-----VRLLSGSREKDRNLRRITRLVLVVVAVFIICWTPIHIFILVEALGST
SHSTAayYFCIALGYTNSSLNPILYAFLDENFKRCFR--------------------
>155:Q9Y5X5 Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2 2 233 2e-71 1 90.5% 22.1% 29:335 142:465
----------------------------HQPQVAAIFIISYFLIFFLCMMGNTVVCFIVMRNKHMHTVTN
LFILNLAISDLLVGIFCMPITLLDNIIAGWPFGNTMCKISGLVQGISVAASVFTLVAIAVDRFQCVVYPF
--KPKLTIKTAFVIIMIIWVLAITIMSPSayYRVRLNSQNKTSPVYWCREDwqEMRKIYTTVLFANIYLA
PLSLIVIMYGRIGISLFRAAVPHTGRKNQEQWHvrKKQKIIKMLLIVALLFILSWLPLWTLMMLSDYADL
SPNEliYPFAHWLAFGNSSVNPIIYGFFNENFRRGFQEAFQLQLCQKRAKPMEAY--
>156:Q804Q2 Melanopsin-B OS=Gadus morhua OX=8049 GN=opn4b PE=2 SV=1 2 234 1e-70 1 89.0% 22.8% 30:331 14:323
-----------------------------PDHAHYVIAFFVLIIGVVGVTGNALVMYAFLCNKKLRTPPN
YFIMNLAVSDFLMAITQSPIFFINSLFKEWIFGETGCRMYAFCGALFGITSMINLLAISLDRYIVITKPP
QAIRWVSGRRTMVVILLVWLYSLAWspLLGWSSYIPEGLMTSCT--WDYVTSTPANKGYTLMLCCFVFFI
PLGIISYCYLCMFLAIRSAGREIERLGTqqQQTIKTEWKLTKVAFVVIIVYVHSWSPYACVTLIaaGYGS
HLSPYSKAVPAVIAKASAIYNPFIYAIIHSKYRDTLAEHVPCLYFLRQPPR------
>157:P46616 Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1 2 228 2e-70 1 86.6% 28.9% 36:329 5:309
-----------------------------------VYITVELVIAVLAILGNVLVCWAVWINSNLQNVTN
YFVVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFFACFVLVLTQSSIFSLLTITIDRYIAIRIPL
RYNGLVTCTRAKGIIAICWVLSFalTPMLGWNNCSQPKGDKNHSESCDEGQVTCLFenYMVYYNFFAflV
PLLLMLGIYLRIFLAARRQLKQMESQpeRTRSTLQKEVHPAKSLAIIVGLFALCCLPLNIINCFTFFCPE
CdpPWLMYLTIILSHGNSVVNPLIYAYRIREFRQTFRKIIRSHILRRRE--------
>158:Q13585 Melatonin-related receptor OS=Homo sapiens OX=9606 GN=GPR50 PE=1 SV=3 2 233 2e-70 1 84.6% 23.6% 25:321 19:310
------------------------PQPEYPPALIIFMFCAMVITIVVDLIGNSMVILAVTKNKKLRNSGN
IFVVSLSVADMLVAIYPYPLMLHAMSIGGWDLSQLQCQMVGFITGLSVVGSIFNIVAIAINRYCYICHSL
QYERIFSVRNTCIYLVITWIMTVLAVLPNMYIGTI--------EYDPRTYTCIFNypVFTVTIVCIHFVL
PLLIVGFCYVRIWTKVLAARDP----AGQNPDNQLAEVRNFLTMFVIFLLFAVCWCPINVLTVLVAVSPk
kIPNWLYLAAYFIAYFNSCLNAVIYGLLNENFRREYWTIFH----------------
>159:O02662 Beta-3 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB3 PE=2 SV=1 2 227 3e-70 1 79.5% 32.3% 48:316 51:356
-----------------------------------------------TVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGATLALTGRWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRCHSNPHCCAFASnyALLSSSVSFYL
PLLVMLFVYARVFLvaRRCASPAAVPSDRLRPapLREHRALRTLGLIVGTFTLCWLPFFVANVMRALGgs
LVPSPALLALNWLGYANSAFNPLIYC-RSPDFRSAF---------------------
>160:Q5IS65 5-hydroxytryptamine receptor 6 OS=Pan troglodytes OX=9598 GN=HTR6 PE=2 SV=1 2 227 6e-70 1 91.7% 31.3% 13:331 7:342
------------PSANSTPAWGAGP-PSAPGGSGWVAAALCVVIALTAAA-NSLLIALICTQPALRNTSN
FFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPL
RYKLRMTPPRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCR---LLASLPFVLVASGLTFFL
PSGAICFTYCRILLAARKQAVQVASLTTGMASqtKHSRKALktLGILLGMFFVTWLPFFVANIVQAVCDC
ISPGL-FDVLTWLGYCNSTMNPIIYPLFMRDFKRA----LGRFLPCPRCPR------
>161:O57422 Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1 2 229 7e-70 1 91.1% 21.5% 30:336 23:335
-----------------------------PDQVLYTIGSFILIIGSVGIIGNMLVLYAFYRNKKLRTAPN
YFIINLAISDFLMSATQAPVCFLSSLHREWILGDIGCNVYAFCGALFGITSMMTLLAISINRYIVITKPL
QSIQWSSKKRTSQIIVLVWMYSLMWSLAPLLGWSSYVPEGLRISCTWDYVTSTMSNRSYTMMLCCCVFFI
PLIVISHCYLFMFLAIRSTGRNVQKlqSFLSQSMKNEWKMAKIAFVIIIVFVLSWSPYACVTLIAWAGHG
KstPYSKTVPAVIAKASAIYNPIIYGIIHPKYRETIHKTVPCLRFLIREPKKDIFE-
>162:P30680 Somatostatin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Sstr2 PE=1 SV=1 2 225 9e-70 1 93.2% 23.1% 2:321 11:328
-SQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITN
IYILNLAIADELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMINVAVWGVslVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSVAI
SPTPAlfDFVVILTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>163:Q95M54 Mu-type opioid receptor OS=Macaca fascicularis OX=9541 GN=OPRM1 PE=2 SV=1 2 225 9e-70 1 90.2% 21.3% 10:319 46:352
---------GPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADALVT-STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPSWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIICWTPIHIYVIIKALVTI
PETTlsWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>164:P34975 Kappa-type opioid receptor OS=Rattus norvegicus OX=10116 GN=Oprk1 PE=2 SV=1 2 225 9e-70 1 92.0% 25.9% 2:317 19:342
-SACLLPNSSSwpNWAESDSNGSVGSEDQQlaIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATN
IYIFNLALADALVT-TTMPFQSAVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPV
KALDFRTPLKAKIINICIWLlsVGISAIVLGGTKVREDVDVIECSLQFPDDEYSWWDLFMKICVFvaFVI
PVLIIIVCYTLMILRLKS-----VRLLSGSREKDRNLRRITKLVLVVVAVFIICWTPIHIFILVEALGST
SHSTAvyYFCIALGYTNSSLNPVLYAFLDENFKRCFR--------------------
>165:Q9MYW9 Mu-type opioid receptor OS=Macaca mulatta OX=9544 GN=OPRM1 PE=2 SV=2 2 225 1e-69 1 90.2% 21.0% 10:319 46:352
---------GPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADALVT-STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMSTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPSWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIICWTPIHIYVIIKALVTI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDEDFKRCFREF------------------
>166:P50406 5-hydroxytryptamine receptor 6 OS=Homo sapiens OX=9606 GN=HTR6 PE=1 SV=1 2 226 1e-69 1 92.3% 31.5% 11:331 5:342
----------PGPTANSTPAWGAGP-PSAPGGSGWVAAALCVVIALTAAA-NSLLIALICTQPALRNTSN
FFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPL
RYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCR---LLASLPFVLVASGLTFFL
PSGAICFTYCRILLAARKQAVQVASLTTGMASqtKHSRKALktLGILLGMFFVTWLPFFVANIVQAVCDC
ISPGL-FDVLTWLGYCNSTMNPIIYPLFMRDFKRA----LGRFLPCPRCPR------
>167:Q8IN35 Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2 2 234 1e-69 1 89.0% 25.0% 25:328 199:517
------------------------PLYRHSLAMSMVYCVAYIVVFLVGLIGNSFVIAVVLRAPRMRTVTN
YFIVNLAIADILVIVFCLPATLIGNIFVPWMLGWLMCKFVPYIQGVSVAASVYSLIAVSLDRFIAIWWPL
---KQMTKRRARIMIIGIWVIALVTtpWLLFFDLVPAEEVFSDALVSAYSQPQFLCQEVWpaNLVACYLL
PMSLITLCYVLIWivSTRSIPGESKDAQMDRMQQKSKVKVIKMLVAVVILFVLSWLPLYVIFARIKFGSD
ISQekVMPVAQWLGSSNSCINPILYS-VNKKYRRGFAAIIKSRSCCGR---------
>168:P33534 Kappa-type opioid receptor OS=Mus musculus OX=10090 GN=Oprk1 PE=1 SV=1 2 224 2e-69 1 92.0% 25.6% 2:317 19:342
-SACLLPNSSSwpNWAESDSNGSVGSEDQQlaIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATN
IYIFNLALADALVT-TTMPFQSAVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPV
KALDFRTPLKAKIINICIWLlsVGISAIVLGGTKVREDVDVIECSLQFPDDEYSWWDLFMKICVFvaFVI
PVLIIIVCYTLMILRLKS-----VRLLSGSREKDRNLRRITKLVLVVVAVFIICWTPIHIFILVEALGST
SHSTAayYFCIALGYTNSSLNPVLYAFLDENFKRCFR--------------------
>169:P34993 Somatostatin receptor type 2 OS=Bos taurus OX=9913 GN=SSTR2 PE=2 SV=1 2 224 2e-69 1 87.2% 25.3% 22:321 30:327
---------------------SNQTEPYYDLASNVVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITN
IYILNLAIADELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMINVAVWGVslVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSVAI
SPTPAlfDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>170:P34994 Somatostatin receptor type 2 OS=Sus scrofa OX=9823 GN=SSTR2 PE=3 SV=1 2 223 4e-69 1 93.5% 24.6% 1:321 3:328
MAYELLNGSQPwnGSVATANSSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITN
IYILNLAIADELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMINVAVWGVslVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSVAI
SPTPAlfDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>171:O15973 Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 2 227 5e-69 1 93.2% 23.7% 1:316 18:343
LNRSMTPNTGWEGPYDMSVHLHWTQFPPVTEEWHYIIGVYITIVGLLGIMGNTTVVYIFSNTKSLRSPSN
LFVVNLAVSDLIfaVNGFPLLTVSSFHQKWIFGSLFCQLYGFVGGVFGLMSINTLTAISIDRYVVITKPL
QASQTMTRRKVHLMIVIVWVLSILLspFFGWGAYIPEGFQTSCTFDYLTKTARTR--TYIVVLYLFGFLI
PLIIIGVCYVLIIRGVRRHDQKMLTITRSmnKRARSELRISKIAMTVTCLFIISWSPYAIIALIAQFGph
WITPLVSELPMMLAKSSSMHNPVVYALSHPKFRKAL---------------------
>172:P30875 Somatostatin receptor type 2 OS=Mus musculus OX=10090 GN=Sstr2 PE=2 SV=1 2 222 6e-69 1 89.9% 23.0% 13:321 22:328
------------NGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITN
IYILNLAIADELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMINVAVWCVslVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSVAI
SPTPAlfDFVVILTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>173:P30874 Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1 2 222 6e-69 1 88.4% 24.0% 18:321 27:328
-----------------STNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITN
IYILNLAIADELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMITMAVWGVslVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSMAI
SPTPAlfDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>174:P79218 Substance-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR2 PE=2 SV=1 2 223 7e-69 1 88.4% 21.8% 27:329 29:331
--------------------------PGWQLALWATAYLAL---VLVAVVGNATVIWIILAHRRMRTVTN
YFIVNLALADLCMATFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSGPGTKAVIAGIWLVALALAFpcFYSTITMDQGATKCVVAWPEDSGGKMLLLYHLTVIALIYFL
PLVVMFVAYSVIGFKLWRRTVPGHQTHGANLRHLRAKKKFVKTMVLVVVTFAVCWLPYHLYFLLGHFQDD
IYcqQVYLVLFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>175:P25929 Neuropeptide Y receptor type 1 OS=Homo sapiens OX=9606 GN=NPY1R PE=1 SV=1 2 223 7e-69 1 96.7% 22.9% 2:333 11:348
-NHSVHSNFSEKNAQLLAFENDDCHL---PLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTN
ILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYVGIAVIWVLAVASSLPFLIYQVMTdtLDAYKDKYVCFDQFPSDSHryTTLLLVLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKMRDNKYRSSETKRINIMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYE----
>176:P56719 Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 2 225 8e-69 1 88.4% 27.3% 29:328 49:387
----------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTN
YFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPL
MFKS--TAKRARNSIVVIWIVSCIIMIPQAIVMERSSMLPGLANKTTLFTVceVYPKMYHICFFLVTYMA
PLCLMVLAYLQIFrvVQRKWKQPQPVSQPriKQIRARRKTARMLMVVLLVFAICYLPISILNVLKRVFGM
FTHtaWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCLGVHR---------
>177:Q5DUB2 Substance-K receptor OS=Canis lupus familiaris OX=9615 GN=TACR2 PE=2 SV=1 2 222 1e-68 1 88.1% 21.3% 30:329 29:331
-----------------------------PGWQLALWATAYLVLVLVAVTGNATVIWIILAHQRMRTVTN
YFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCHFQNLFPITAMFVSIYSMTAIAADRYVAIVHPF
--QPRLSAPGTRAVIAGIWLLALALAFpfYSTITMDQGATKCVVVWPEDNGSKMLL-LYHLVVIALIYVL
PLLVMLLAYSVIGLTLWRREVPRHQVHGASLRHLRAKKKFVKTMVLVVVTFAICWLPYHFYFILGSFQeh
KFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>178:P30549 Substance-K receptor OS=Mus musculus OX=10090 GN=Tacr2 PE=2 SV=1 2 222 1e-68 1 86.9% 21.4% 27:325 29:327
--------------------------PGWQLALWATAYLAL---VLVAVTGNATVIWIILAHERMRTVTN
YFIINLALADLCMAAFNATFNFIYASHNIWYFGSTFCYFQNLFPVTAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSAPSTKAVIAVIWLVALALASpfYSTITVDQGATKCVVAWPNDNGGKMLL-LYHLVVFVLIYFL
PLVVMFAAYSVIGLTLWKRAVPRHQAHGANLRHLQAKKKFVKAMVLVVVTFAICWLPYHLYFILGTFQED
ifIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPW------------
>179:P16610 Substance-K receptor OS=Rattus norvegicus OX=10116 GN=Tacr2 PE=2 SV=1 2 222 1e-68 1 88.1% 21.5% 27:329 29:331
--------------------------PGWQLALWATAYLAL---VLVAVTGNATVIWIILAHERMRTVTN
YFIINLALADLCMAAFNATFNFIYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSAPSTKAIIAGIWLVALALASpfYSTITVDEGATKCVVAWPNDNGGKMLL-LYHLVVFVLIYFL
PLLVMFGAYSVIGLTLWKRAVPRHQAHGANLRHLQAKKKFVKAMVLVVLTFAICWLPYHLYFILGTFQeh
KFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>180:Q5YKK9 Melanopsin OS=Felis catus OX=9685 GN=OPN4 PE=2 SV=1 2 225 1e-68 1 87.8% 23.2% 25:322 56:362
------------------------PTVDVPDHAHYTLGTVILLVGLTGILGNLMVIYTFCRSRGLRTPAN
MFIINLAVSDFFMSFTQAPVFFASSLHKRWLFGEAGCEFYAFCGALFGITSMITLMAIALDRYLVITHPL
ATIGVVSKRRAALVLLGVWLYALAWspFFGWSAYVPEGLLTSCS--WDYMSFTPSVRAYTMLLFCFVFFL
PLLVIVYCYIFIFRAIRerACEGGGRSPRQRQRLQREWKMAKIELLVILLFVLSWAPYSIVALMaaGYAH
VLTPYMNSVPAVIAKASAIHNPIIYAITHPKYRMAIAQHLPC---------------
>181:O02835 Neuropeptide Y receptor type 1 OS=Sus scrofa OX=9823 GN=NPY1R PE=2 SV=2 2 222 1e-68 1 97.0% 22.8% 2:334 11:349
-NHSIYYNFSEKNSQFLAFENDDCHL---PLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTN
ILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEVMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPSNRHAYVGIAVIWVLAVASSLPFLIYQVLTDEPFQNVTLDAFKDKYVCFDksYTTLLLVLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKMRDNKYRSSETKRINVMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCINPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYEV---
>182:P21452 Substance-K receptor OS=Homo sapiens OX=9606 GN=TACR2 PE=1 SV=3 2 222 2e-68 1 88.4% 21.8% 27:329 29:331
--------------------------PSWQLALWATAYLAL---VLVAVTGNAIVIWIILAHRRMRTVTN
YFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSAPSTKAVIAGIWLVALALASpcFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFL
PLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQeh
KFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>183:Q6XL69 Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1 2 225 2e-68 1 85.8% 23.7% 30:320 60:355
-----------------------------PDHAHYIIGAVILIVGITGVIGNALVIYVFCRSRTLRTAGN
MFVVNLAVADFFMSLTQSPVFFAASLHRRWIFGERICELYAFCGALFGICSMMTLTAIAADRCLAITQPL
ALVGNVSRRKAGAVLAVVWLYSLGWspFFGWSAYVPEGLQTSCS--WDYMTFTPSVRAYTILLFIFVFFI
PLGIIVSCYVGIFQAIRAMGKEIREltQKVYERMQNEWKMAKIALLVILLFVISWSPYSVVALTATaySH
LLTPYMNSVPAVIAKASAIHNPIIYAITHPKYRAAIARYI-----------------
>184:P13945 Beta-3 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB3 PE=1 SV=3 2 222 2e-68 1 79.5% 32.0% 48:316 51:356
-----------------------------------------------TVGGNLLVIVAIAWTPRLQTMTN
VFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASnyVLLSSSVSFYL
PLLVMLFVYARVFVVATRQLRLLRGerRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGgs
LVPGPAFLALNWLGYANSAFNPLIYC-RSPDFRSAF---------------------
>185:P58308 Orexin receptor type 2 OS=Mus musculus OX=10090 GN=Hcrtr2 PE=2 SV=2 2 224 3e-68 1 87.2% 27.7% 29:324 49:383
----------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTN
YFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPL
MFKS--TAKRARNSIVVIWIVSCIIMIPQAIVMECSSMLPGLANKTTLFTVceVYPKMYHICFFLVTYMA
PLCLMILAYLQIFrvVQRKWKQQQPVSQPriKQIRARRKTARMLMVVLLVFAICYLPISILNVLKRVFGM
FTHtaWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCL-------------
>186:Q64077 Substance-K receptor OS=Cavia porcellus OX=10141 GN=TACR2 PE=2 SV=1 2 222 3e-68 1 88.4% 22.1% 27:329 29:331
--------------------------PTWQLALWATAYLAL---VLVAVTGNATVTWIILAHQRMRTVTN
YFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAIDRYMAIVHPF
--QPRLSAPSTKAVIGGIWLVALALAFpcFYSTITEDEGATKCVVAWPEDSRDKSLLLYHLVVIVLIYLL
PLTVMFVAYSIIGLTLWRRAVPRHQAHGANLRHLQAKKKFVKTMVLVVVTFAICWLPYHLYFILGSFQeh
KFIQQVYLALFWLAMSSTMYNPIIYCCLNRRFRSGFRLAFRCCPWVTPT--------
>187:Q1RMU8 Neuropeptide Y receptor type 1 OS=Bos taurus OX=9913 GN=NPY1R PE=2 SV=1 2 221 3e-68 1 96.7% 23.5% 2:333 11:348
-NHSIYYNFSEKNSRFLAFENDDCHL---PLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTN
ILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYVGIAVIWVLAVASSLPFLIYQVLTDEPFQNVTLDAFKDKYVCFDksYTTLLLVLQYFG
PLCFIFICYFKIYVRLKRRNSMMDKMRDNKYRSSEAKRINIMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFSFCDFRSRDDDYE----
>188:Q49LX6 Somatostatin receptor type 2 OS=Canis lupus familiaris OX=9615 GN=SSTR2 PE=3 SV=1 2 220 3e-68 1 87.5% 24.3% 21:321 30:328
--------------------SSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITN
IYILNLAIAGELF-MLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPI
KSAKWRRPRTAKMVNVAVWGVSLLVvpIMIYAGLRSNQWGRSSCTINWPGESGTWYTGFIIYTFILGFLV
PLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK-----VTRMVSIVVAVFIFCWLPFYIFNVSSVSVAI
SPTPAlfDLVVVLTYANSCANPILYAFLSDNFKKSFQNVLC----------------
>189:P34989 Opsin, longwave 563 nm (Fragment) OS=Callithrix jacchus OX=9483 PE=1 SV=1 2 220 4e-68 1 91.1% 23.7% 8:324 25:334
-------NSNSTRGPFEGPNYHIAPRWVYHLTSVWMLFV-----VVASVFTNGLVLAATMKFKKLRHPLN
WILVNLAIADLAETVIASTISVVNQVHGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIVGVAFSWIWSAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMITCCFL
PLGIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMIVAYCVCWGPyfFACFAAANPGY
AFHPLMAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>190:O62809 Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2 2 223 4e-68 1 87.5% 26.9% 29:325 49:384
----------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTN
YFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPL
MFKS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTMLPGLANKTTLFTVceIYPKMYHICFFLVTYMA
PLCLMVLAYLQIFrvVQRKWKPLQPVSQPriKQIRARRKTARMLMVVLLVFAICYLPISILNVLKRVFGM
FTHtaWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCL------------
>191:Q9TUP7 Orexin receptor type 2 OS=Canis lupus familiaris OX=9615 GN=HCRTR2 PE=1 SV=1 2 223 4e-68 1 87.5% 26.9% 29:325 49:384
----------------------------HPKEYEWVLIAGYIIVFVVALVGNVLVCVAVWKNHHMRTVTN
YFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPL
MFKS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTMLPGLANKTTLFTVceIYPKMYHICFFLVTYMA
PLCLMVLAYLQIFrvVQRKWKPLQPASQPriKQIRARRKTARMLMVVLLVFAICYLPISILNVLKRVFGM
FTHtaWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCL------------
>192:O18913 Long-wave-sensitive opsin 1 OS=Felis catus OX=9685 GN=OPN1LW PE=2 SV=2 2 220 4e-68 1 91.1% 23.3% 8:324 32:341
-------NSNATRGPFEGPNYHIAPRWVYHVTSAWMIFV-----VIASVFTNGLVLAATMKFKKLRHPLN
WILVNLAVADLAETIIASTISVVNQIYGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIAGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMITCCII
PLSVIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVMVMIFAYCVCWGPyfFACFAAAHPGY
AFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCIMQLFGKKV-------------
>193:Q95170 Long-wave-sensitive opsin 1 OS=Capra hircus OX=9925 GN=OPN1LW PE=1 SV=1 2 220 5e-68 1 91.1% 23.7% 8:324 32:341
-------NSNSTRDPFEGPNYHIAPRWVYHLTSAWMVFV-----VIASVFTNGLVLAATMRFKKLRHPLN
WILVNLAIADLAETIIASTISVVNQMYGYFVLGHPLCVVEGYTVSLCGITGLWSLAIISWERWMVVCKPF
G-NVRFDAKLATAGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMITCCFI
PLSVIILCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVMVMIFAYCLCWGPyfFACFAAAHPGY
AFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>194:P28646 Somatostatin receptor type 1 OS=Rattus norvegicus OX=10116 GN=Sstr1 PE=2 SV=1 2 221 5e-68 1 91.4% 23.5% 7:321 30:339
------PGSGAADGMEEPGRNSSQNGtsEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATN
IYILNLAIADELL-MLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPI
KAARYRRPTVAKVVNLGVWVLslVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLL
PVGAICLCYVLIIAK-----MRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQ
-DDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILC----------------
>195:P30974 Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2 2 224 6e-68 1 88.1% 21.7% 25:324 70:382
------------------------PSPTRPYELPwiWAIIFGLMMFVAIAGNGIVLWIVTGHRSMRTVTN
YFLLNLSIADLLMSSLNCVFNFIFMLNSDWPFGSIYCTINNFVANVTVSTSVFTLVAISFDRYIAIVHPL
--KRRTSRRKVRIILVLIWALSCVLSAplLYSSIMTKHYYNGKSRTVCFMMwsMADYAYNLIILVLTYGI
PMIVMLICYSLMGRVLW-GSRSIGENTDRQMESMKSKRKVVRMFIAIVSIFAICWLPYHLFFIYAYHNNQ
VASTkmYLGFYWLAMSNAMVNPLIYYWMNKRFRMYFQRIICCCC-------------
>196:Q9BGI7 Long-wave-sensitive opsin 1 OS=Bos taurus OX=9913 GN=OPN1LW PE=2 SV=1 2 220 6e-68 1 91.1% 23.7% 8:324 32:341
-------NSNSTRDPFEGPNYHIAPRWVYHLTSAWMVFV-----VIASVFTNGLVLAATMRFKKLRHPLN
WILVNLAIADLAETIIASTISVVNQMYGYFVLGHPLCVVEGYTVSLCGITGLWSLAIISWERWMVVCKPF
G-NVRFDAKLAITGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMITCCFI
PLSVIILCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVMVMIFAYCLCWGPyfFACFAAAHPGY
AFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>197:Q4U4D2 Melanopsin OS=Podarcis siculus OX=65484 GN=OPN4 PE=2 SV=2 2 223 6e-68 1 92.6% 24.5% 22:335 2:324
---------------------GTQHRIKVDVPDRVLYTVGSCVLViiGITGNLLVLYAFYSNKRLRTPAN
YFIMNLAASDFLMSATQAPICFLNSMHTEWILGDIGCNFYVFCGALFGITSMMTLLAISVDRYCVITKPL
QSIKRSSKKRSCIIIAFVWLYSLGWspLFGWSSYIPEGLMISCT--WDYVSYSPANRSYTMMLCCFVFFI
PLIIIFHCYLFMFLAIRSTGRNVQKLGSTYNRkvKSEWKLAKIAFVAIVVFVLSWSPYACVTLIAWAGYA
KtnPYSKSVPAVIAKASAIYNPIIYAIIHPRYRRTIRSAVPCLRFLIRISPSDLS--
>198:P30937 Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 2 220 7e-68 1 83.1% 25.1% 35:321 44:323
----------------------------------VTIQCIYALVCLVGLVGNALVIFVILRYAKMKTATN
IYLLNLAVADELF-MLSVPFVASAAALRHWPFGAVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPL
RAATYRRPSVAKLINLGVWLASLLVTLPIAVFADTRPARGGEAVACNLHWPHPAWSAVFVIYTFLLGFLL
PVLAIGLCYLLIVGKMRAVA-----LRAGWQQRRRSEKKITRLVLMVVTVFVLCWMPFYVVQLLNLFVTS
L-DATVNHVSLILSYANSCANPILYGFLSDNFRRSFQRVLC----------------
>199:Q1JPS6 Melanopsin-like OS=Danio rerio OX=7955 GN=opn4l PE=2 SV=1 2 223 8e-68 1 85.8% 24.4% 30:320 60:355
-----------------------------PDHAHYIIGSVILIVGITGVIGNALVVYVFCRSRTLRTAGN
MFIVNLAVADFLMSVTQSPVFFAASLHRRWVFGERPCELYAFCGALFGICSMMTLTAIAADRCLAITQPL
ALVSRVSRRKAGAVLVVVWLYSLGWspFFGWSAYVPEGLQTSCS--WDYMTFTPSVRAYTILLFVFVFFI
PLGIIGSCYFAIFQTIRAAGKEIREltHKVYERMQNEWKMAKVALVVIVLFIISWSPYSVVALTATaySH
FLTPYMNSVPAVIAKASAIHNPIIYAITHPKYRVAIARYI-----------------
>200:Q924H0 Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2 2 221 1e-67 1 86.4% 22.5% 29:321 40:348
----------------------------HQPQVAAVFISSYLLIFVLCMVGNTVVCFIVIRNRHMHTVTN
FFILNLAISDLLVGIFCMPITLLDNIIAGWPFGSSMCKISGLVQGISVAASVFTLVAIAVDRFRCVVYPF
--KPKLTVKTAFVTIVIIWGLAIAIMTPSAIMLHVQEEKYYRVRLSSHNKTSTVYWCryTTVLFATIYLA
PLSLIVIMYARIGASLFKTAAHCTGKQRPVQWHVSKKkkVIKMLLTVALLFILSWLPLWTLMMLSDYTDl
iINIYIYPFAHWLAFCNSSVNPIIYGFFNENFRNGFQDAFQ----------------
>201:Q9R1C8 5-hydroxytryptamine receptor 6 OS=Mus musculus OX=10090 GN=Htr6 PE=1 SV=1 2 221 1e-67 1 93.2% 28.6% 11:328 3:345
----------PEPGPVNSSTPAWGPGPPPAPGGSGWVAAALCVVIVLTAAANSLLIALICTQPALRNTSN
FFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPL
RYKLRMTAPRALALILGAWSLAALASFLPLLLGWHELGKARTSAPGQCR---LLASLPYVLVASGVTFFL
PSGAICFTYCRILLAARKQAVQVASLtdSRRLTTKHSRKALktLGILLSMFFVTWLPFFVASIAQAVCDC
ISPGL-FDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFVPCVHCPPE---------
>202:P30873 Somatostatin receptor type 1 OS=Mus musculus OX=10090 GN=Sstr1 PE=1 SV=1 2 220 1e-67 1 91.4% 23.5% 7:321 30:339
------PGSGAADGMEEPGRNASQNGtsEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATN
IYILNLAIADELL-MLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPI
KAARYRRPTVAKVVNLGVWVLslVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLL
PVGAICLCYVLIIAK-----MRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQ
-DDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILC----------------
>203:O18914 Long-wave-sensitive opsin 1 OS=Canis lupus familiaris OX=9615 GN=OPN1LW PE=2 SV=2 2 219 2e-67 1 91.1% 24.0% 8:324 32:341
-------NSNATRDPFEGPNYHIAPRWVYHLTSAWMIFV-----VIASVFTNGLVLVATMRFKKLRHPLN
WILVNLAIADLAETIIASTISVVNQIYGYFVLGHPLCVVEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIAGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMTTCCII
PLSVIILCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVLAYCLCWGPyfFACFAAAHPGY
AFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>204:P04000 Long-wave-sensitive opsin 1 OS=Homo sapiens OX=9606 GN=OPN1LW PE=1 SV=1 2 219 2e-67 1 91.1% 23.7% 8:324 32:341
-------NSNSTRGPFEGPNYHIAPRWVYHLTSVWMIFVVTA-----SVFTNGLVLAATMKFKKLRHPLN
WILVNLAVADLAETVIASTISIVNQVSGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIVGIAFSWIWSAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMVTCCII
PLAIIMLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMIFAYCVCWGPyfFACFAAANPGY
AFHPLMAALPAYFAKSATIYNPVIYVFMNRQFRNCILQLFGKKV-------------
>205:P51144 Substance-K receptor OS=Mesocricetus auratus OX=10036 GN=TACR2 PE=2 SV=1 2 219 2e-67 1 88.1% 21.3% 30:329 29:331
-----------------------------PAWQLALWATAYLGLVLVAVTGNATVIWIILAHERMRTVTN
YFIINLALADLCMAAFNATFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSAPITKATIAGIWLVALALASpfYSTITVDQGATKCVVAWPNDNGGKMLL-LYHLVVFVLVYFL
PLVVMFVAYSVIGLTLWKRAVPRHQAHGANLRHLHAKKKFVKAMVLVVLTFAICWLPYHLYFILGSFQKD
ifIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>206:Q5XXP2 Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1 2 221 2e-67 1 87.8% 22.5% 25:322 60:363
------------------------PTVDVPDHAHYILGTVILLVGLTGMLGNLTVIYTFCRSRSLRTPAN
MLIINLAVSDFLMSFTQAPVFFASSLYKKWLFGETGCEFYAFCGAVLGITSMITLTAIALDRYLVITRPL
ATIGMGSKRRTALVLLGIWLYALAWspFFGWSAYVPEGLLTSCS--WDYVTFTPQVRAYTMLLFCFVFFL
PLLVIIFCYISIFRAIrcEGWSESPQRRRQWHRLQSEWKMAKVALIVILLFVLSWAPYSTVALVaaGYSH
ILTPYMSSVPAVIAKASAIHNPIVYAITHPKYRAAIAQHLPC---------------
>207:Q9WVD0 Neuropeptide Y receptor type 1 OS=Cavia porcellus OX=10141 GN=NPY1R PE=3 SV=1 2 219 2e-67 1 94.4% 23.8% 10:333 19:348
---------SEEKPSFFAFENDDCHL---PLAVIFTLALAYGAVIILGVSGNLALILIILKQKEMRNVTN
ILIVNLSFSDLLVAIMCLPFTFVYTLMDHWIFGEIMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYIGIAVIWVLAVASSLPFMIYQVLTdtLDAFKDKLVCFDQFPSDSHryTTLLLVLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKMRDSKYRSSESKRINIMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYE----
>208:O43614 Orexin receptor type 2 OS=Homo sapiens OX=9606 GN=HCRTR2 PE=1 SV=2 2 220 3e-67 1 87.5% 26.9% 29:325 49:384
----------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTN
YFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPL
MFKS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVceIYPKMYHICFFLVTYMA
PLCLMVLAYLQIFrvVQRKWKPLQPVSQPriKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGM
ftVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCL------------
>209:Q60613 Adenosine receptor A2a OS=Mus musculus OX=10090 GN=Adora2a PE=2 SV=3 2 219 3e-67 1 86.9% 26.8% 36:330 5:308
-----------------------------------VYIMVELAIAVLAILGNVLVCWAVWINSNLQNVTN
FFVVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPL
RYNGLVTGMRAKGIIAICWVLSFalTPMLGWNNCSQKDENSTKTCGEGRVTCLFEDVVPMNYMVYYNFFA
FvlLMLAIYLRIFLAARRQLKQMESQpeRTRSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCST
CqpPWLMYLAIILSHSNSVVNPFIYAYRIREFRQTFRKIIRTHVLRRQEP-------
>210:Q61224 5-hydroxytryptamine receptor 1D OS=Mus musculus OX=10090 GN=Htr1d PE=2 SV=2 2 218 3e-67 1 92.3% 32.4% 6:323 8:371
-----LEGLPQEASNRSLNVTGAW-DPEVLQALRISLVVVLSVITLATVLSNAFVLTTILLTKKLHTPAN
YLIGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGHAAAMIAAVWIISICISIPPLF---WRQATAHEEMSDCLVNTSQISYT---IYSTCGAFYI
PSILLIILYGRIYVAARSRILNPPSLYGKRFTTAqrERKATKTLGIILGAFIICWLPFFVVSLVLPICrc
WIHPALFDFFTWLGYLNSLINPVIYTVFNEDFRQAFQKVVHFR--------------
>211:P30543 Adenosine receptor A2a OS=Rattus norvegicus OX=10116 GN=Adora2a PE=1 SV=2 2 219 4e-67 1 88.1% 27.7% 31:330 1:308
------------------------------MGSSVYITVELAIAVL-AILGNVLVCWAVWINSNLQNVTN
FFVVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPL
RYNGLVTGVRAKGIIAICWVLSFalTPMLGWNNCSQKDGNSTKTCGEGRVTCLFEDVVPMNYMVYYNFFA
FvlLMLAIYLRIFLAARRQLKQMESQpeRTRSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCST
caPPWLMYLAIILSHSNSVVNPFIYAYRIREFRQTFRKIIRTHVLRRQEP-------
>212:P31388 5-hydroxytryptamine receptor 6 OS=Rattus norvegicus OX=10116 GN=Htr6 PE=1 SV=2 2 220 4e-67 1 93.2% 29.9% 11:328 3:343
----------PEPGPVNSSTPAWGPGPPPAPGGSGWVAAALCVVIVLTAAANSLLIVLICTQPALRNTSN
FFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPL
RYKLRMTAPRALALILGAWSLAALASFLPLLLGWHELGKARTPAPGQCR---LLASLPFVLVASGVTFFL
PSGAICFTYCRILLAARKQAVQVASLtdSRRLATKHSRKALktLGILLGMFFVTWLPFFVANIAQAVCDC
ISPGL-FDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCVHCPPE---------
>213:P05363 Substance-K receptor OS=Bos taurus OX=9913 GN=TACR2 PE=2 SV=1 2 218 5e-67 1 88.4% 20.0% 30:329 29:331
-----------------------------PGWQLALWTAAYLALVLVAVMGNATVIWIILAHQRMRTVTN
YFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPF
--QPRLSAPGTRAVIAGIWLVALALAFpcFYSTITTDEGATKCVVAWPEDSGGKMLLLYHLIVIALIYFL
PLVVMFVAYSVIGLTLWRRSVPGHQAHGANLRHLQAKKKFVKTMVLVVVTFAICWLPYHLYFILGTFQeh
KFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPT--------
>214:Q9EQD2 Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1 2 219 5e-67 1 86.9% 22.7% 29:323 40:350
----------------------------HQPHVTAVFISSYFLIFFLCMVGNTVVCFVVIRNRYMHTVTN
FFIFNLAISDLLVGIFCMPITLLDNIIAGWPFGSSMCKISGLVQGISVAASVFTLVAIAVDRFRCVVYPF
--KPKLTVKTAFVMIVIIWGLAITIMTPSayYRVRLSSHNKTSTVYWCREDwqEMRRIYTTVLFATIYLA
PLSLIVIMYARIGASLFKTSAHSTGKQreQWHVSKKKQKVIKMLLTVALLFILSWLPLWTLMMLSDYADL
SPNKlvYPFAHWLAFCNSSVNPIIYGFFNENFRSGFQDAFQFC--------------
>215:O02836 Neuropeptide Y receptor type 2 OS=Sus scrofa OX=9823 GN=NPY2R PE=2 SV=2 2 218 6e-67 1 92.3% 24.3% 7:323 24:344
------PGHTTPRGELAPDSEPELKDSTKLIEVQIILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTN
FFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHL
E--SKISKRISFLIIGLAWGISALlsPLAIFREYSLIEIIPDFEIVACTEKwkSIYGTVYSLSSLLILYv
pLGIISFSYARIWSKLKNHVSP----GGVNDHYHQRRQKTTKMLVCVVVVFAVSWLPLHAFQLAVDilDL
KEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCE--------------
>216:P33535 Mu-type opioid receptor OS=Rattus norvegicus OX=10116 GN=Oprm1 PE=1 SV=1 2 218 6e-67 1 86.1% 22.6% 24:319 57:350
-----------------------CPQTGSPSMVTAITIMaySIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>217:P28565 5-hydroxytryptamine receptor 1D OS=Rattus norvegicus OX=10116 GN=Htr1d PE=2 SV=1 2 217 7e-67 1 84.9% 33.6% 32:323 33:371
-------------------------------ALRISLVVVLSIITLATVLSNAFVLTTILLTKKLHTPAN
YLIGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDAL
EYSKRRTAGHAAAMIAAVWAISICISIPPLF---WRQATAHEEMSDCLVNTSQISYT---IYSTCGAFYI
PSILLIILYGRIYVAARSRILNPPSLYGKRFTTAqrERKATKTLGIILGAFIICWLPFFVVSLVLPICrc
WIHPALFDFFTWLGYLNSLINPVIYTVFNEDFRQAFQRVVHFR--------------
>218:P42866 Mu-type opioid receptor OS=Mus musculus OX=10090 GN=Oprm1 PE=1 SV=1 2 218 8e-67 1 86.1% 22.6% 24:319 57:350
-----------------------CPQTGSPSMVTAITIMaySIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>219:P30975 Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 2 221 9e-67 1 87.5% 24.8% 30:327 97:403
-----------------------------PWWRQVLWSILFGGMVIVATGGNLIVVWIVMTTKRMRTVTN
YFIVNLSIADAMVSSLNVTFNYYYMLDSDWPFGEFYCKLSQFIAMLSICASVFTLMAISIDRYVAIIRPL
--QPRMSKRCNLAIAAVIWLASTLIspMMIIYRTEEVPVRGLSNRTVCYPEwsTMESLYNILIIILTYFL
PIVSMTVTYSRVGIELW-GSKTIGECTPRQVENVRSKRRVVKMMIVVVLIFAICWLPFHSYFIITSCYPA
ItiQELYLAIYWLAMSNSMYNPIIYCWMNSRFRYGFKMVFRWCLFVR----------
>220:Q9R024 Medium-wave-sensitive opsin 1 OS=Cavia porcellus OX=10141 GN=OPN1MW PE=2 SV=1 2 216 1e-66 1 91.1% 23.7% 8:324 32:341
-------NSNNTRGPFEGPNYHIAPRWVYHLTSAWM-----TIVVIASIFTNGLVLVATMRFKKLRHPLN
WILVNLAVADLAETVIASTISVVNQVYGYFVLGHPLCVVEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIVGIVFSWVWSAVWtpIFGWSRYWPYGLKTSCGPDVFSGTSYPGVQSYMMVLMVTCCIT
PLSIIVLCYLHVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVLAYCLCWGPyfFACFATANPGY
SFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>221:P30938 Somatostatin receptor type 5 OS=Rattus norvegicus OX=10116 GN=Sstr5 PE=1 SV=2 2 216 1e-66 1 90.2% 26.0% 11:321 13:320
----------NASAASSGNHNWSLVGSASPMGARAVLVPVLYLlcTVGLSGNTLVIYVVLRHAKMKTVTN
VYILNLAVADVLFMLGLPFLATQNAVVSYWPFGSFLCRLVMTLDGINQFTSIFCLMVMSVDRYLAVVHPL
RSARWRRPRVAKMASAAVWVFSLLMSLPLLVFADVQEGWGTCNLSWPEP--VGLWGAAFITYTSVLGFFG
PLLVICLCYLLIVVKVKAAGMRV-----GSSRRRRSEPKVTRMVVVVVLVFVGCWLPFFIVNIVNLAFTL
PEEPtlYFFVVVLSYANSCANPLLYGFLSDNFRQSFRKVLC----------------
>222:Q5IS84 Mu-type opioid receptor OS=Saimiri boliviensis boliviensis OX=39432 GN=OPRM1 PE=2 SV=1 2 217 1e-66 1 87.2% 23.0% 20:319 55:352
-------------------SDSPCPPTGSPSMITAITIMaySIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIVNVCNWIISSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>223:P49660 Somatostatin receptor type 4 OS=Mus musculus OX=10090 GN=Sstr4 PE=1 SV=2 2 217 1e-66 1 83.1% 25.1% 35:321 45:324
----------------------------------VTIQCIYALVCLVGLVGNALVIFVILRYAKMKTATN
IYLLNLAVADELF-MLSVPFARSAAALRHWPFGAVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPL
ATATYRRPSVAKLINLGVWLASLLVTLPIAVFADTRPARGGEAVACNLHWPHPAWSAVFVIYTFLLGFLP
PVLAIGLCYLLIVGKMRAVA-----LAGGWQQRRRSEKKITRLVLMVVTVFVLCWMPFYVVQLLNLFVTS
L-DATVNHVSLILSYANSCANPILYGFLSDNFRRSFQRVLC----------------
>224:P0DN78 Medium-wave-sensitive opsin 3 OS=Homo sapiens OX=9606 GN=OPN1MW3 PE=3 SV=1 2 216 2e-66 1 91.1% 23.3% 8:324 32:341
-------NSNSTRGPFEGPNYHIAPRWVYHLTSVWMIFV-----VIASVFTNGLVLAATMKFKKLRHPLN
WILVNLAVADLAETVIASTISVVNQVYGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWMVVCKPF
G-NVRFDAKLAIVGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMVTCCIT
PLSIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVLAFCFCWGPYAFFACFAAapGY
PFHPLMAALPAFFAKSATIYNPVIYVFMNRQFRNCILQLFGKKV-------------
>225:P0DN77 Medium-wave-sensitive opsin 2 OS=Homo sapiens OX=9606 GN=OPN1MW2 PE=3 SV=1 2 216 2e-66 1 91.1% 23.3% 8:324 32:341
-------NSNSTRGPFEGPNYHIAPRWVYHLTSVWMIFV-----VIASVFTNGLVLAATMKFKKLRHPLN
WILVNLAVADLAETVIASTISVVNQVYGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWMVVCKPF
G-NVRFDAKLAIVGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMVTCCIT
PLSIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVLAFCFCWGPYAFFACFAAapGY
PFHPLMAALPAFFAKSATIYNPVIYVFMNRQFRNCILQLFGKKV-------------
>226:P04001 Medium-wave-sensitive opsin 1 OS=Homo sapiens OX=9606 GN=OPN1MW PE=1 SV=1 2 216 2e-66 1 91.1% 23.3% 8:324 32:341
-------NSNSTRGPFEGPNYHIAPRWVYHLTSVWMIFV-----VIASVFTNGLVLAATMKFKKLRHPLN
WILVNLAVADLAETVIASTISVVNQVYGYFVLGHPMCVLEGYTVSLCGITGLWSLAIISWERWMVVCKPF
G-NVRFDAKLAIVGIAFSWIWAAVWtpIFGWSRYWPHGLKTSCGPDVFSGSSYPGVQSYMIVLMVTCCIT
PLSIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVLAFCFCWGPYAFFACFAAapGY
PFHPLMAALPAFFAKSATIYNPVIYVFMNRQFRNCILQLFGKKV-------------
>227:Q28558 Melatonin-related receptor OS=Ovis aries OX=9940 GN=GPR50 PE=2 SV=2 2 221 2e-66 1 84.6% 24.2% 25:321 19:310
------------------------PQPDYPPALIVFMFCAMVITIVVDLIGNSMVILAVSKNKKLRNSGN
VFVVSLSVADMLVAIYPYPLMLHAMAIGGWDLSKLQCQMVGFITGLSVVGSIFNIMAIAINRYCYICHSL
QYERIFSVRNTCIYLAVTWIMTVLAVLPNMYIGTI--------EYDPRTYTCIFNypAFAVTIVCIHFVL
PLLIVGFCYVKIWTKVLAARDP----AGQNPDNQLAEVRNFLTMFVIFLLFAVCWCPINALTVLVAvmAG
KIPNWVYLAAYFIAYFNSCLNAVIYGVLNENFRREYWTIFH----------------
>228:Q04573 Neuropeptide Y receptor type 1 OS=Mus musculus OX=10090 GN=Npy1r PE=1 SV=1 2 216 2e-66 1 94.7% 22.5% 9:333 17:347
--------NASENSPLLAFENDDCHL---PLAVIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTN
ILIVNLSFSDLLVAVMCLPFTFVYTLMDHWVFGETMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYIGITVIWVLAVASSLPFVIYQILTDEPFQNVSLAAFKDKYVCFDksYTTLLLVLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKIRDSKYRSSETKRINIMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYE----
>229:P21555 Neuropeptide Y receptor type 1 OS=Rattus norvegicus OX=10116 GN=Npy1r PE=1 SV=3 2 216 2e-66 1 94.1% 22.9% 11:333 19:347
----------SENSPFLAFENDDCHL---PLAVIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTN
ILIVNLSFSDLLVAVMCLPFTFVYTLMDHWVFGETMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYIGITVIWVLAVASSLPFVIYQILTDEPFQNVSLAAFKDKYVCFDksYTTLLLVLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKIRDSKYRSSETKRINVMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYE----
>230:P46626 Beta-3 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB3 PE=2 SV=1 2 216 4e-66 1 81.6% 33.0% 48:323 51:363
-----------------------------------------------TVGGNLLVIVAIARTPRLQTMTN
VFVTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPL
RYGALVTKRRALAAVVLVWVVSAAVSFAPIMSKWWRIGADAEAQRChnPRCCTFASNMPYALlsSVSFYL
PLLVMLFVYARVFVVAtsPAGVPSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRALGgs
LVSGPTFLALNWLGYANSAFNPLIYC-RSPDFRSAFRRLLCRC--------------
>231:Q32ZE2 Adenosine receptor A2b OS=Oryctolagus cuniculus OX=9986 GN=ADORA2B PE=2 SV=1 2 214 5e-66 1 87.2% 31.0% 31:327 3:312
------------------------------LETQDALYVALELAIalSVAGNVLVCAAVGTSSALQTPTN
YFLVSLAAADVAVGLFAIPFAITISLGFCTDFHS--CLFLACFVLVLTQSSIFSLLAVAVDRYLAILVPL
RYKSLVTGTRARGVIAVLWVLaiGLTPFLGwtANCTEPRDGTTNESCCLVKCLFENVVPMSYMVYFNFfp
PLLIMLAIYIKIFLVACRQLQRTELMDHSRTTLQR-EIHAAKSLAMIVGIFALCWLPVHAINCVTLFQpk
DKPKWAMNTAILLSHANSVVNPIVYAYRNRDFRETFHKIISRYVLCQ----------
>232:Q5IS39 Mu-type opioid receptor OS=Pan troglodytes OX=9598 GN=OPRM1 PE=2 SV=1 2 216 6e-66 1 90.2% 21.3% 10:319 47:353
---------GPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRHGSIDCTLTFSHPTWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>233:Q9Z2D5 Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1 2 215 6e-66 1 92.3% 24.0% 7:323 24:344
------PGHTTPRGELAPDPEPELIDSTKLTEVRVVLILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTN
FFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTVTLTVIALDRHRCIVYHL
--DSKISKQNSFLIIGLAWGISALlsPLAIFREYSLIEIIPDFEIVACTEKwkSIYGTVYSLSSLLILYv
pLGIISVSYVRIWSKLKNHVSP----GAANDHYHQRRQKTTKMLVFVVVVFAVSWLPLHAFQLAVDilDL
KEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCQ--------------
>234:P97295 Neuropeptide Y receptor type 2 OS=Mus musculus OX=10090 GN=Npy2r PE=2 SV=2 2 215 7e-66 1 92.3% 24.6% 7:323 23:343
------PGHTTPRGELPPDPEPELIDSTKLVEVQVILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTN
FFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHL
E--SKISKRISFLIIGLAWGISALlsPLAIFREYSLIEIIPDFEIVACTEKwkSVYGTVYSLSTLLILYv
pLGIISFSYTRIWSKLRNHVSP----GAASDHYHQRRHKMTKMLVCVVVVFAVSWLPLHAFQLAVDilDL
KEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCE--------------
>235:P41145 Kappa-type opioid receptor OS=Homo sapiens OX=9606 GN=OPRK1 PE=1 SV=2 2 215 7e-66 1 90.5% 24.4% 7:317 31:342
------PGWAEPDSNGSAGSEDAQLEPAhsPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATN
IYIFNLALADALVT-TTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPV
KALDFRTPLKAKIINICIWLlsVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVffAFVI
PVLIIIVCYTLMILRLKS-----VRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGST
SHSTAayYFCIALGYTNSSLNPILYAFLDENFKRCFR--------------------
>236:O02813 Neuropeptide Y receptor type 1 OS=Canis lupus familiaris OX=9615 GN=NPY1R PE=2 SV=2 2 215 7e-66 1 94.1% 22.6% 11:333 19:347
----------SENSQFLAFESDDCHL---PLAMIFTLALAYGAVIILGVTGNLALIMIILKQKEMRNVTN
ILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPR
GW--RPNNRHAYVGIAVIWVLAVVSSLPFLIYQVLTDEPFQNVTLDAFKDKYVCFDksYTTLLLMLQYFG
PLCFIFICYFKIYIRLKRRNNMMDKMRDNKYRSSETKRINIMLLSIVV-AFAVCWLPLTIFNTvhQIIAT
CNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYE----
>237:O08726 Galanin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Galr2 PE=2 SV=1 2 215 7e-66 1 89.6% 23.9% 6:319 1:306
-----MNGSGSQGAENTSQEGGSGGWQPE----AVLVPLFFALIFLVGTVGNALVLAVLLRGGQAVSTTN
LFILNLGVADLCFILCCVPFQATIYTLDDWVFGSLLCKAVHFLIFLTMHASSFTLAAVSLDRYLAIRYPL
HSRELRTPRNALAAIGLIWGLALLFSGPYLSYYRQ----SQLANLTVCHPAWSAPRRRAMDLCTFvsYLL
PVLVLSLTYARTLRYLWRTVDPVTAGSGSQ----RAKRKVTRMIIIVAVLFCLCWMPHHALILCVWFGRF
PLTRATYalSHLVSYANSCVNPIVYALVSKHFRKGFRKI------------------
>238:P29275 Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=2 SV=1 2 213 8e-66 1 87.2% 31.6% 31:327 3:312
------------------------------LETQDALYVAllVIAALSVAGNVLVCAAVGTANTLQTPTN
YFLVSLAAADVAVGLFAIPFAITISLGFCTDF--YGCLFLACFVLVLTQSSIFSLLAVAVDRYLAICVPL
RYKSLVTGTRARGVIAVLWVLaiGLTPFLGwtNNCTEPWDGTTNESCCLVKCLFENVVPMSYMVYFNFfp
PLLIMLVIYIKIFLVACRQLQRTELMDHSRTTLQR-EIHAAKSLAMIVGIFALCWLPVHAVNCVTLfqGK
NKPKWAMNMAILLSHANSVVNPIVYAYRNRDFRYTFHKIISRYLLCQ----------
>239:Q2KIP6 Kappa-type opioid receptor OS=Bos taurus OX=9913 GN=OPRK1 PE=2 SV=1 2 215 9e-66 1 90.2% 25.7% 7:317 25:342
------NGSGWFPGWAEPDGNGSapAHISPV-ILVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATN
IYIFNLALADALVT-TTMPFQSTVYLMNSWPFGDVLCKVVISIDYYNMFTSIFTLTMMSVDRYIAVCHPV
KALDFRTPLKAKIINICIWIlsVGISAIVLGGTKVREDMEVIECSLQFPDDDYSWWDLFMKVCVFvaFVI
PVLIIIVCYTLMILRLKS-----VRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGST
AHSTAayYFCIALGYTNSSLNPILYAFLDENFKRCFR--------------------
>240:P35372 Mu-type opioid receptor OS=Homo sapiens OX=9606 GN=OPRM1 PE=1 SV=2 2 215 1e-65 1 90.2% 21.3% 10:319 46:352
---------GPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATN
IYIFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPV
KALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIM
PVLIITVCYGLMILRLKSVRML-----SGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTI
pfQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREF------------------
>241:Q96P65 Pyroglutamylated RFamide peptide receptor OS=Homo sapiens OX=9606 GN=QRFPR PE=2 SV=2 2 216 1e-65 1 84.6% 22.5% 30:314 41:341
-----------------------------PGRAKLALVLTGVLIFALALFGNALVFYVVTRSKAMRTVTN
IFICSLALSDLLITFFCIPVTMLQNISDNWLGGAFICKMVPFVQSTAVVTEILTMTCIAVERHQGLVHPF
KMKWQYTNRRAFTMLGVVWLVAVIVGSPMWHVQQLEIKYDFLyeHICCLEEWTSPVHqyTTFILVILFLL
PLMVMLILYSKIGYELWIksVLRTIHGKEMSKIARKKKRAVIMMVTVVALFAVCWAPFHVVHMMIEYSNf
vTIKMIFAIVQIIGFSNSICNPIVYAFMNENFKK-----------------------
>242:O08858 Somatostatin receptor type 5 OS=Mus musculus OX=10090 GN=Sstr5 PE=1 SV=3 2 214 1e-65 1 79.2% 27.6% 47:321 50:319
----------------------------------------------VGLGGNTLVIYVVLRYAKMKTVTN
VYILNLAVADVLF-MLGLPFLATQNAVSYWPFGSFLCRLVMTLDGINQFTSIFCLMVMSVDRYLAVVHPL
RSARWRRPRVAKLASAAVWVFSLLMSLPLLVFADVQEGWGTCNLSWPEP--VGLWGAAFITYTSVLGFFG
PLLVICLCYLLIVVKVKAAGMRV-----GSSRRRRSERKVTRMVVVVVLVFVGCWLPFFIVNIVNLAFTL
PEEPtlYFFVVVLSYANSCANPLLYGFLSDNFRQSFRKALC----------------
>243:P22909 Alpha-2A adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra2a PE=1 SV=2 2 217 1e-65 1 66.5% 33.0% 3:229 2:226
--GSLQPDAGNSSWNGTEAPGGGTRATPYSLQVTLTLVCLAGLLMLFTVFGNVLVIIAVFTSRALKAPQN
LFLVSLASADILVATLVIPFSLANEVMGYWYFGKVWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAI
EYNLKRTPRRIKAIIVTVWVISAVISFPPLISIEKKGAGGG---QQPAEPSCKINDQKWYVisSIGSFFA
PCLIMILVYVRIYQIAKRR---------------------------------------------------
---------------------------------------------------------
>244:Q49LX5 Somatostatin receptor type 1 OS=Canis lupus familiaris OX=9615 GN=SSTR1 PE=3 SV=1 2 214 2e-65 1 89.0% 23.2% 11:321 38:338
----------EEPGRNASQ-NGTLSEGQGS---AILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATN
IYILNLAIADELL-MLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPI
KAARYRRPTVAKVVNLGVWVLslVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLL
PVGAICLCYVLIIAK-----MRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQ
D-DATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILC----------------
>444:O35478 Medium-wave-sensitive opsin 1 OS=Sciurus carolinensis OX=30640 GN=OPN1MW PE=2 SV=2 2 218 4e-67 1 91.1% 23.3% 8:324 32:341
-------NSNATRGPFEGPNYHIAPRWVYHITSTWMI-----IVVIASVFTNGLVLVATMKFKKLRHPLN
WILVNLAIADLAETVIASTISVVNQLYGYFVLGHPLCVVEGYTVSVCGITGLWSLAIISWERWLVVCKPF
G-NMRFDAKLAIVGIAFSWIWSAVWtpIFGWSRYWPYGLKTSCGPDVFSGTSYPGVQSYMMVLMVTCCII
PLSIIILCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVFAYCLCWGPyfFACFATANPGY
AFHPLVAALPAYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>445:O18910 Medium-wave-sensitive opsin 1 OS=Oryctolagus cuniculus OX=9986 GN=OPN1MW PE=1 SV=2 2 217 8e-67 1 91.1% 23.7% 8:324 32:341
-------NSNSTRGPFEGPNFHIAPRWVYHLTSAWMI-----LVVIASVFTNGLVLVATMRFKKLRHPLN
WILVNLAVADLAETVIASTISVVNQFYGYFVLGHPLCVVEGYTVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLAIAGIAFSWIWAAVWtpIFGWSRYWPYGLKTSCGPDVFSGTSYPGVQSYMMVLMVTCCII
PLSVIVLCYLQVWMAIRTVAKQ----QKESESTQKAEKEVTRMVVVMVFAYCLCWGPyfFACFATAHPGY
SFHPLVAAIPSYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>446:P41592 Red-sensitive opsin OS=Anolis carolinensis OX=28377 PE=1 SV=1 2 217 1e-66 1 91.1% 23.3% 8:324 35:344
-------NSNNTRGPFEGPNYHIAPRWVYNITSVWMIFV-----VIASIFTNGLVLVATAKFKKLRHPLN
WILVNLAIADLGETVIASTISVINQISGYFILGHPMCVLEGYTVSTCGISALWSLAVISWERWVVVCKPF
G-NVKFDAKLAVAGIVFSWVWSAVWTApfGWSRYWPHGLKTSCGPDVFSGSDDPGVLSYMIVLMITCCFI
PLAVILLCYLQVWLAIRAVAAQ----QKESESTQKAEKEVSRMVVVMIIAYCFCWGPYTVFafAAANPGY
AFHPLAAALPAYFAKSATIYNPIIYVFMNRQFRNCIMQLFGKKV-------------
>447:O35476 Medium-wave-sensitive opsin 1 OS=Rattus norvegicus OX=10116 GN=Opn1mw PE=1 SV=2 2 216 2e-66 1 91.1% 24.0% 8:324 27:336
-------NSNSTRGPFEGPNYHIAPRWVYHLTSTWMI-----LVVIASVFTNGLVLAATMRFKKLRHPLN
WILVNLAVADLAETIIASTISVVNQIYGYFVLGHPLCVIEGYIVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLATVGIVFSWVWAAVWtpIFGWSRYWPYGLKTSCGPDVFSGTSYPGVQSYMMVLMVTCCIF
PLSIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVFAYCLCWGPyfFACFATAHPGY
AFHPLVASLPSYFAKSATIYNPIIYVFMNRQFRNCILQLFGKKV-------------
>448:O35599 Medium-wave-sensitive opsin 1 OS=Mus musculus OX=10090 GN=Opn1mw PE=1 SV=1 2 215 3e-66 1 91.1% 24.0% 8:324 27:336
-------NSNSTKGPFEGPNYHIAPRWVYHLTSTWMI-----LVVVASVFTNGLVLAATMRFKKLRHPLN
WILVNLAVADLAETIIASTISVVNQIYGYFVLGHPLCVIEGYIVSLCGITGLWSLAIISWERWLVVCKPF
G-NVRFDAKLATVGIVFSWVWAAIWtpIFGWSRYWPYGLKTSCGPDVFSGTSYPGVQSYMMVLMVTCCIF
PLSIIVLCYLQVWLAIRAVAKQ----QKESESTQKAEKEVTRMVVVMVFAYCLCWGPyfFACFATAHPGY
AFHPLVASLPSYFAKSATIYNPIIYVFMNRQFRNCILHLFGKKV-------------
>449:Q804X9 Melanopsin-A OS=Gadus morhua OX=8049 GN=opn4a PE=2 SV=1 2 220 4e-66 1 84.6% 22.6% 30:316 26:320
-----------------------------PDHAHYTVAFFVSVIGTLGVTGNALVQFAFYSNKKLRNLPN
YFIMNQAASDFLMAFTQSPFFFINCLNREWIFGELGCKLYAFLGALFGITSMINLLAISLDRYMVITRPL
EAMKWNSKRRTTIAILLVWLYSLAWspLVGWSSYIPEGLRTSCT--WDYVTYTASNRSYTMMLCCFVFFI
PLAIISYCYLFMFLAIRKTSRDVERLGIqrQKSIRTEWKLAKIAFVVIVVYVLSWSPYACVTMISWSGhn
ILSPYSKTVPAVIAKASTIYNPFIYAIIHQKYRKTL---------------------
